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ABSTRACT 
 
 
This dissertation research explored mechanisms of human milk 
(HM) expulsion by describing the effects of skin to skin contact 
(SSC) on maternal basal oxytocin (OT) secretion among 20 
premature mothers with hospitalized premature infants. This one-
group, repeated measures design consisted of: 1) daily SSC with 
covariant data via self-report diary and 2) maternal salivary OT 
with and without SSC at 4 time points were collected over a 7 
day time frame. Results indicate that mean levels of basal OT 
increase over time (M 234 pg/ml, SD 108 pg/ml time point 1; M 
257 pg/ml, SD 125 pg/ml time point 3). Through multilevel model 
data analysis basal OT was found to have a meaningful amount of 
dependence on SSC frequency (t(16) = 6.389, p = < 0.001) and SSC 
duration (t(17) = 6.867, p = < 0.001) with coefficient estimates 
that indicate that basal OT exposed to 75-85 minutes of SSC per 
day are 92 pg/ml higher. These findings provide preliminary data 
that suggest that lactating mothers with premature infants 
sustain positive effects of SSC that increase basal OT secretion 
over time.   
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CHAPTER ONE: 
INTRODUCTION 
 
 
 
Introduction to the Problem 
 
Infant mortality among the 3.6 million infant deaths 
reported by the World Health Organization (Robert et al., 2010) 
occurred within the first 28 days of life with nearly 50% within 
the first 24 hours relative to prematurity, infections and 
asphyxia. In the United States, medical advancements in neonatal 
resuscitation have improved survival rates of infants at birth. 
However, prematurity remains one of the top three leading causes 
of death annually (Mathew & MacDorman, 2011). Of the surviving 
premature infants, many are at high risk for comorbidities, such 
as necrotizing enterocolitis (NEC), sepsis, and impaired neuro-
cognitive development (Gartner et al., 2005). Immediate 
postnatal care with an emphasis on neonatal warmth and early 
initiation of breastfeeding are effective interventions that 
reduce infant mortality and prevent co-morbidities of 
prematurity (Robert et al., 2010; Ganapathy, Hay, & Kim, 2012; 
Meier, Engstrom, Patel, Jegier, & Bruns, 2010). Compared to 
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conventional incubator care, skin to skin contact (SSC) equally 
stabilizes neonatal warmth and thermoregulation (Bystrova et 
al., 2003). However, SSC is more effective in positive 
breastfeeding outcomes (Aghdas, Talat, & Sepideh, 2013; Hurst, 
Valentine, Renfro, Burns, & Ferlic, 1997).   
 
Statement of the Problem  
Despite the evidence that supports the benefits of SSC and 
breastfeeding, SSC is seldom practiced in western cultures 
(Moore, Anderson, Bergman & Dowswell, 2012). In addition, 
breastfeeding rates for postpartum mothers of premature infants 
are statistically lower than women who birth healthy term 
infants. Mothers of premature infants who successfully initiate 
breastfeeding are less likely to sustain breastfeeding until 
neonatal discharge because of low human milk volume (Spatz, 
2004; Zanardo et al., 2011).  
Mechanisms that impact human milk volume are complex, with 
bio-behavioral underpinnings. Immediately after delivery, 
mothers with premature infants are often physically challenged 
by pregnancy complications, trauma associated with preterm 
delivery, and mentally challenged by barriers in privacy, 
overall concern for their infants’ health and emotional distress 
secondary to grief, loss or separation (Sisk, Quandt, Parson, & 
Tucker, 2010; Shah, Clements & Poehlmann, 2011). These 
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compounding circumstances often induce additional psychological 
stressors that manifest maternal feelings of fatigue, anxiety, 
stress or even depression (Obeidat, Bond, & Callister, 2009; 
Morelius, Theodorsson, & Nelson, 2005; Flacking, 2007; Sisk et 
al., 2010; Shah et al., 2011). Physiologically, such bio-
behavioral stressors negatively affect the physiology of human 
milk synthesis by inhibiting the secretion of lactogenic 
hormones necessary to stimulate lactogenesis (i.e. human milk 
synthesis)(Buhimschi, 2004; Dewey, 2001; Bruckmaier & Wellnitz, 
2008; Ueda, Yokoyama, Irahara & Aono, 1994; Newton, M. & Newton, 
N. R.,1948). 
During lactogenesis, oxytocin is an important hormone 
responsible for galactokinesis, a process in which human milk is 
ejected from the mammary gland (Buhimschi, 2004). A poor 
ejection reflex due to insufficient oxytocin secretion 
perpetuates a cycle that negatively affects the amount of human 
milk expelled from the mammary glands. This in turn leads to 
lactation failure due to inadequate human milk volume 
(Buhimschi, 2004).  
An increase in oxytocin secretion can be triggered in 
response to non-noxious stimuli such as touch or massage among 
animal subjects (Uvnas-Moberg, 1996). Similarly, tactile 
stimulation via infant holding has been shown to enhance 
oxytocin secretion among lactating mothers of full term human 
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infants (Ueda et al., 1994). Additionally, tactile stimulation 
via direct SSC has been shown to positively influence human milk 
volume among mothers with preterm infants (Hurst, 2007; Hill et 
al., 2009). Conceivably, SSC can be an effective method that 
enhances both oxytocin secretion and human milk volume. However, 
the true clinical significance of the relationship between SSC 
and basal oxytocin levels on human milk volume have yet to be 
determined.  
 
Purpose of the Study 
 
The purpose of this research is to explore mechanisms of 
galactokinesis by analyzing the effects of SSC on maternal 
oxytocin basal salivary levels among lactating mothers with 
hospitalized premature infants. Findings from this research are 
expected to inform the long term research goal of a program of 
research on biobehavioral mechanisms of SSC on human lactation 
and maternal psychological health.    
 
Specific Aims 
The aims of this study are:  
Aim 1: Explore the relationship between basal salivary oxytocin 
levels and amount of skin to skin contact (SSC) among lactating 
mothers with hospitalized premature infants.  
Research Questions:  
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1a. Does maternal basal salivary oxytocin differ across 7 
days in mothers before SSC? 
1b. Does SSC frequency affect basal salivary oxytocin 
levels?  
1c. Does SSC duration affect basal salivary oxytocin 
levels? 
 
Definition of Relevant Terms 
Skin to Skin Contact (SSC) occurs when a naked neonate is 
placed prone on his/her mother’s bare chest (Moore et al., 
2012). The use of early SSC immediate post birth has been known 
to reduce infant mortality (Lawn, Mwansa-Kambafwile, Horta, 
Barros, & Cousens, 2010). Beyond the first hour of birth, 
intermittent and continuous SSC among premature infants 
regulates neonatal oxygen saturation, heart rate, breathing, 
glucose and assists transitioning neonates to breastfeed 
(Bergman, Linley, & Fawcus, 2004; Nyqvist et al., 2010).  
Lactogenesis is a two stage process of human milk synthesis 
(Hurst, 2007). Stage I represents the onset of human milk 
synthesis initiated during the second trimester of pregnancy. 
Once the placenta is expelled after birth, progesterone levels 
decline rapidly and prolactin is secreted (Buhimschi, 2004; 
Nedkova & Tanchev, 1995). Within four days postpartum, 
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increasing prolactin levels then trigger the beginning of 
copious milk synthesis known as lactogenesis II (Hurst, 2007). 
Oxytocin is a nine amino acid neuropeptide secreted from the 
posterior pituitary gland responsible for uterine contractility 
at birth and human milk ejection during lactation (Gabor, 2012). 
More recent studies among the social sciences have linked oxytocin 
as an important biomarker that facilitates parental affiliation 
and stress modulation within animal and human subjects (Feldman, 
Gordon, & Zagoory-Sharon, 2011. Synchronous maternal-infant 
behaviors found in these studies implicates that mothers who 
provide more affectionate tactile contact have an increase in 
oxytocin release following maternal-child interaction. 
Galactokinesis is the process in which human milk is 
ejected from the mammary gland (Buhimschi, 2004). During 
breastfeeding, nerve impulses generated from areolar stimulation 
via massage and suckling activate the central nervous system to 
elicit the pulsatile release of oxytocin from the posterior 
pituitary (Matthiesen, Ransjö-Arvidson, Nissen, & Uvnäs-Moberg, 
2001; Ueda, Yokoyama, Irahara, & Aono, 1994). Excreted oxytocin 
is then carried through the blood stream to the mammary gland, 
where oxytocin finally attaches to epithelial cell receptors 
located on milk-secreting alveoli in the milk ducts. This causes 
the milk duct cells to contract, resulting in expulsion of milk 
from the mammary gland (Hurst, 2007). 
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Assumptions  
 
Mothers with premature infants in the neonatal intensive 
care unit experience stressors that trigger episodes of 
depression, anxiety (Carvalho, Linhares, Padovani, & Martinez, 
2009; Padovani, Linhares, Pinto, Duarte, & Martinez, 2008; 
Ukpong, Fatoye, Oseni, & Adewuya, 2003) and elevated cortisol 
levels. Over time, the recurrent practice of SSC intervention 
has been shown to reduce maternal cortisol levels by 32% 
(Morelius et al., 2005). This evidence suggests that SSC can be 
considered a behavior that down regulates psychological stress 
responses. However, due to the complexity of such a phenomenon, 
inclusion of stress as a dependent variable is beyond the scope 
of this research and will not be measured. Nonetheless based on 
the SSC research discussed earlier by Morelius et al. (2005) it 
is assumed that post-partum mothers of premature infants are 
experiencing a high stress state prior to SSC intervention. 
 
 
Significance  
 
This study has a high level of significance for nursing 
science because it explores a new biomarker that will aid in 
describing the relationship between SSC and secretion of 
oxytocin lactogenic hormone. Secretion of oxytocin has been 
known to elicit maternal “feel good” responses that improve 
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maternal mood (Samuel et al., 2015). A new understanding of the 
relationship of SSC and basal oxytocin level is expected to 
emerge that adds to the understanding of the physiology of 
galactokinesis or human milk expulsion. These finding may 
indirectly explain how to sustain exclusive human milk feedings 
for premature infants. Immunologic benefits of breast milk, 
consumed by the premature infant via exclusive human milk 
feedings offers a significant contribution to neonatal health 
care outcomes by reducing the incidences of neonatal 
complications associated with premature delivery, such as 
sepsis, NEC, and death.  
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CHAPTER TWO: 
LITERATURE REVIEW 
 
Objective  
 The objective of this chapter is to review and critique 
scientific evidence that supports current knowledge of skin to 
skin contact, oxytocin and human milk volume. First, an 
introduction to the topic with reference to breastfeeding rates 
among premature infants will provide data that supports the 
significance of the problem. Next, linkages between maternal-
infant factors that contribute to insufficient human milk volume 
will be summarized based on an evidence based schematic. 
Additional biobehavioral factors that influence insufficient 
human milk volume will be further discussed to emphasize the 
compounding effects of the maternal-infant relationship on human 
milk synthesis. Physiologic effects of compounding factors among 
lactating women will be further analyzed to understand maternal 
stress responses that may inhibit lactogenesis and 
galactokinesis. Mediating effects of skin to skin contact (SSC) 
will be presented as a means to deregulate maternal stress 
responses in order to influence oxytocin and galactokinesis. 
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Concluding remarks will provide a summary that identifies gaps 
in the literature requiring further research and present a logic 
model that aims to fill the gaps by exploring the relationship 
between basal salivary oxytocin levels and SSC.  
Literature considered for this review was extracted from 
PubMed, CINAHL and Web of Science databases utilizing a 
combination of keywords with “skin to skin contact”, “kangaroo 
care”, “breastfeeding”, “human milk volume”, “prematurity” and 
“oxytocin”. Three-hundred and ten abstracts were retrieved and 
reviewed for content.  After excluding systematic reviews, print 
duplications, irrelevant literature and animal model designs, 31 
studies were included for review. 
 
Human Milk Feedings and Premature Infants 
The American Academy of Pediatrics (2012) recommends 
exclusive breastfeeding for the first six month of life as the 
gold standard of nutrition for all newborns, including premature 
infants. Nutritional benefits of exclusive human milk feedings 
support optimal growth and development, while immunologic 
components reduce risks of necrotizing enterocolitis, sepsis and 
death (Gartner et al., 2011; Patel et al., 2013). Statistically, 
breastfeeding initiation rates for postpartum mothers of 
premature infants are significantly lower than women who birth 
healthy term infants and fewer than 50% of these mothers sustain 
15 
 
breastfeeding until neonatal discharge due to insufficient human 
milk volume (less than 500 milliliters per 24 hours 7-10 days 
post-partum) (Hill & Aldag, 2005; Hill, Aldag, & Chatterton, 
1999; Spatz, 2004).  
Insufficient human milk volume was identified as one of the 
leading causes for breastfeeding cessation by the Centers for 
Disease Control and Prevention (Li, Fein, Chen, & Grummer-
Strawn, 2008) among 1,323 lactating mothers of full-term or late 
preterm infants weighing at least 5 pounds at birth. Self-report 
questionnaires completed by participants queried whether or not 
mothers had stopped breastfeeding or pumping for her infant. 
Those who answered yes were then asked to rate the importance of 
32 reasons for breastfeeding cessation on a 4-point Likert scale 
ranging from not important to very important. The top seven 
factors that accounted for 54% of the motives for breastfeeding 
cessation included: (1) lactation issues related to latch-on or 
nipple/breast problems, (2) psychosocial reasons related to 
breastfeeding attitudes and social support, (3) nutritional 
concerns about milk supply, (4) lifestyle issues related to 
diet, smoking, and autonomy, (5) medical reasons related to the 
mother's or infant's illness, (6) milk pumping concerns related 
to mothers willingness or accessibility to express breast milk, 
and (7) self-weaning issues related to biting or losing 
interest. Regardless of the weaning age, the most consistent 
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reason for breastfeeding cessation of the top seven factors 
among 43-55% of all participants included perceptions of 
insufficient milk supply.  
 
Insufficient Human Milk Volume Schematic  
Dewey (2001) links perceptions of insufficient milk supply 
to biologic and behavioral stressors that influence the 
physiology of human milk synthesis in a schematic that 
identifies two causative pathways that influence insufficient 
human milk volume related to the birthing process. The first 
pathway originates with mode of delivery (e.g. vaginal vs. 
cesarean birth), while the second originates with medications 
necessary for birth (e.g. epidurals). Conceptually, adverse 
birthing outcomes that influence the mode of delivery also 
influence medications necessary for birth, likewise, medications 
that are not tolerated by the fetus during the labor influence 
the mode of delivery. Secondary stressors that are precipitated 
by mode of delivery and medications include duration/difficulty 
of labor and infant suck reflex. In response to these stressors, 
human milk production is compromised because of a delay in 
breastfeeding onset or nipple stimulation. Effects of a 
suppressed suckle-induced hormone response lead to insufficient 
human milk volume until mechanisms of human milk synthesis 
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(lactogenesis) and human milk ejection (galactokinesis) are 
restored. 
In addition to these pathways, Dewey (2001) further 
describes how the reciprocal nature of maternal-infant 
breastfeeding relationship inversely influences human milk 
volume. For example, early gestational age impacts the infant’s 
suckling behavior at the breast. Ineffective suckling of the 
breast can trigger a delayed onset of milk synthesis which can 
inversely cause the mother to be stressed resulting in 
insufficient human milk volume. These compounding effects can 
negatively affect the physiology of lactogenesis and 
galactokinesis (Table 1).  
 McNeilly, Robinson, Houston, and Howie (1983) measured 
physiologic effects of infant suckling behavior in a small 
sample. One group included five women in early stages of 
lactogenesis and the second group included five women in later 
stages of lactogenesis. Among all women, oxytocin was found to 
be released in a pulsatile manner during suckling with higher 
concentrations three to 10 minutes before suckling began. 
Stimuli that triggered the release of oxytocin were in response 
to the baby crying (n=5), the baby becoming restless in 
expectation of the feed (n=3) and as the mother prepared for the 
feeding (n=2).  Stimulation of the nipple during suckling was 
the only stimuli that solicited prolactin release. These results 
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indicate milk ejection reflex, with release of oxytocin, occurs 
in most women before the tactile stimulus of suckling with a 
second release of oxytocin in response to the suckling stimuli 
itself. Implications of the study indicate that lack of suckling 
stimulation or ineffective suckling behavior can delay the 
release of lactogenic hormone and result in a poor milk ejection 
reflex. Results also implicate that breastfeeding mothers should 
be protected from stress during suckling and immediately before 
nipple stimulation, when a conditioned release of oxytocin is 
expected to occur to prevent the inhibition of oxytocin 
secretion (McNeilly et al., 1983). 
 
Additional Factors that Influence Human Milk Synthesis & Volume 
Multiple maternal-infant factors influence human milk 
synthesis (Table 2). Biologic factors that adversely affect the 
physiology of human synthesis and ejection reflex include: 
parity, mode of delivery, body mass index, comorbidities, 
smoking, medications, breast anatomy, stress, anxiety, infant 
gestational age and weight (Fuertes, Santos, Beeghly, & Tronick, 
2006; Gizzo et al., 2012; Handlin et al., 2012; Hill et al., 
1999). Behavioral factors that indirectly impact human milk 
synthesis include: maternal self-efficacy and motivation to 
breastfeed, nursing frequency, method of nipple stimulation, use 
of supplements or pacifiers, social support and infant 
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temperament (Acuna-Muga et al., 2014; Hill & Aldag, 2005; Hill 
et al., 1999; Keemer, 2013; Riordan, Woodley, & Heaton, 1994). 
Psychosocial constructs and social determinants also highly 
impact breastfeeding duration in addition to maternal perception 
of human milk volume (Li, Fein, Chen, & Grummer-Strawn, 2008). 
Hispanics and mothers with household incomes significantly lower 
than the federal poverty level are most likely to stop 
breastfeeding prematurely.  Other social determinants include 
maternal demographics like women of younger age, unmarried, 
primiparous, lower education, enrollment in government women 
infant and children nutrition programs (WIC) programs, and a 
resident of the Midwest or the South (Li, Fein, Chen, & Grummer-
Strawn, 2008).  
 
Physiologic Effects of Biobehavioral Factors that Influence 
Human Milk Synthesis & Volume 
As mentioned in Dewey’s (2001) schematic, compounding 
effects of biobehavioral factors related to the maternal-infant 
breastfeeding relationship induce psychologic stress responses.  
Zanardo et al. (2011) addressed psychological distress on 
lactation performance in mothers with late preterm infants. This 
study enrolled 42 mothers with singleton infants born 34-36 
weeks gestation. After consent, participants completed a self-
report survey identifying select socio-demographics, feeding 
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preference, psychosocial care, pre and post pregnancy. Each 
participant was interviewed for 30 minutes 3-4 days postpartum 
to complete three validated questionnaires: (1) State-Trait 
Anxiety Inventory (STAI), (2) the Edinburgh Postnatal Depression 
Scale (EPDS) and (3) the Psychological Stress Measure. Data 
analysis revealed that mothers who delivered late preterm 
infants had significantly lower breastfeeding rates had 
significantly higher levels of depression, stress, and anxiety 
compared to mothers of term infants. While this data helped 
identify that psychological stressors induced by physiologic 
(pain) or emotional (anxiety) measures negatively affected 
breastfeeding, the inclusion of lactogenic biomarkers limits the 
knowledge gained about the relationship of psychologic stressors 
on lactogenic hormone secretion, human milk synthesis and 
perhaps human milk volume.  
Animal model research designs were the first to identify 
that hypothalamic-pituitary axis (HPA) reactivity to physical 
and emotional stressors were lessened during lactation (Neumann 
et al., 1998). Tu, Lupien and Walker (2006) tested this 
hypothesis among human subjects by investigating HPA 
responsiveness related to feeding methods and psychological 
stressors among human subjects. Sixty-six women enrolled were in 
between 5-20 weeks postpartum. Participants were asked to 
participate in two stress exposure sessions. One was the 
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standard Trier Social Stress Test and the other an emotional 
video evoking threats to children. Participants that were 
breastfeeding ended up with reduced responsiveness to the Trier 
Social Stress Test and child-related stressors. Tu and Lupien 
(2006) hypothesized that such findings may indicate that changes 
in neural mechanisms that modulate the HPA axis during pregnancy 
and lactation desensitize stress circuits, thus reducing the 
overall stress induced cortisol secretion.   
Groer and Davis (2006) concur with the desensitization and 
down-regulated HPA stress response phenomenon, but perceived the 
phenomenon as a protective measure in lactating women. This was 
evidenced by their cross sectional study that compared mothers 
exclusively breastfeeding verses formula feeding. Among formula 
feeding mothers, biomarkers (serum levels of interferon-gamma 
and interleukin-10) were decreased in addition to elevated 
perceived stress, mood and negative life experience.  
Given that lactogenic hormone secretion (oxytocin) depends 
on the activation of the HPA, it is possible that 
desensitization may negatively affect lactogenic hormone 
secretion from the posterior pituitary gland. As early as 1948, 
Newton and Newton identified inhibitory effects of lactogenic 
hormone secretion in response to acute stressful stimuli. Ueda 
et al.(1994) evaluated implications of acute stress among 22 
exclusively breastfeeding women. Participants were assigned to 
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one of three groups categorized on external stress exposure. 
Group 1 was the control group in which there was no external 
stress exposure, group 2 was the mental stress group in which 
participants were exposed to cognitive stressors of verbal math 
problem calculations, and group 3 was the noise stress group in 
which participants were exposed to sounds of building 
construction at a mean of 70 decibels.  Serum oxytocin samples 
were collected every 2 minutes before and after breastfeeding 
and during measuring milk transfer pre and post weights. 
Frequency of pulsatile release of oxytocin was significantly 
lower in both stress exposed groups. These findings support the 
hypothesis that stress negatively affects lactogenesis by 
inhibiting oxytocin release during galactokinesis. Further 
applications of Ueda et al.’s (1994) findings speculate that 
suckling induced oxytocin release may be regulated by the 
central nervous system; indicating that psychological relaxation 
may be essential for an adequate milk ejection let-down 
response. 
 
Mediating Effects of Skin to Skin Contact on Stress Responses 
SSC has been known to promote psychological relaxation by 
mediating stress and anxiety through attachment and bonding 
behaviors (Dalbye, Calais, & Berg, 2011; Tessier et al., 1998). 
In response to stressful stimuli, Heinrichs et al. (2001) 
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enrolled forty-three lactating women. Prior to stress exposure 
one group was asked to breastfeed and the other to solely hold 
their infants for a 15 minute period. Thirty minutes prior the 
intervention, participants were exposed to a brief psychological 
stress test measuring anxiety, known as the Trier Social Stress 
Test. In this procedure, participants were asked to perform or 
speak in front of a panel and then asked to verbally answer a 
mathematical question. Salivary or serum cortisol levels were 
collected pre, post and during the stress test respectively. No 
differences in baseline cortisol levels were identified between 
the groups before the stress test. In response to stress 
exposure, adrenocorticotropic hormone, total plasma cortisol, 
salivary free cortisol, norepinephrine, and epinephrine were 
significantly increased in all lactating women (p < 0.001). 
However, total plasma cortisol and salivary free cortisol 
responses to stress were less among breastfeeding women (p = 
0.001 and p = 0.067). Additionally, both breastfeeding and 
holding interventions led to decreased anxiety (p < 0.05), 
whereas, stress exposure worsened psychologic symptoms of mood, 
calmness, and anxiety in total (p < 0.001). Researchers 
concluded that breastfeeding and tactile stimulation via holding 
interventions may be further explored as effective mechanisms 
applicable for reducing psychological stressors.  
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Among premature infants, SSC mediates neonatal stress 
responses up to 6 hours post extra-uterine life by stabilizing 
cardiopulmonary function (Bergman, Linley, & Fawcus, 2004). SSC 
also mediates breastfeeding outcomes by facilitating priming of 
the olfactory neuro-pathway (Winberg & Porter, 1998). Like other 
mammals, newborns exhibit primitive innate reflexes to self-
attach to their mother’s nipple. Immediately after birth, 
newborns take up to 60 minutes to go through nine phases that 
lead them to self-attach to the breast (Widstrom et al., 2011). 
Cognitively, preterm infants may not have the capacity to self-
attach to the breast but are able to gradually transition to 
breastfeed with the practice of SSC intervention (Spatz, 2004).  
SSC position gives neonates the opportunity to smell the scent 
of their mother’s milk due to the close proximity to the breast. 
Breast odors from the mother exert a pheromone-like effect where 
the newborn learns to recognize their own mother's unique odor 
and locate the mother’s nipple to initiate breastfeeding (Winberg 
& Porter, 1998). By the time premature infants are ready to be 
discharged home, premature infants exposed to SSC repeatedly 
verses infants exposed to conventional incubator care with SSC 
are more likely to receive exclusive breastmilk feedings 
(Ghavane et al., 2012). However, due to multiple confounders 
(neonatal environments, maternal-infant separation, gestation 
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age, breast pumping frequency, etc) further correlative studies 
are warranted to fully understand how and why SSC promotes 
positive breastfeeding outcomes. Further understanding of the 
relationship of oxytocin secretion and SSC frequency and 
duration is expected to add to this knowledge.  
 
Oxytocin and Skin to Skin Contact 
Research synthesized by Kerstin Uvnas-Moberg (1998) 
suggests that oxytocin plays a role in positive social 
interaction, stress regulation and neuroendocrine functionality 
necessary for motherhood and lactation. In this framework 
positive social interactions between the mother and the newborn 
are expected to begin immediately after birth where the mother 
is expected to provide milk, warmth, and protection of her 
offspring. During this early period of social interaction, 
oxytocin performs two functions. First it allows for milk to be 
ejected in response to non-noxious stimuli like infantile 
suckling. Second it transmits warmth to her young by 
vasodilating blood vessels in the skin that overlay the mammary 
gland (Uvnäs-Moberg, 1996). Reciprocal effects of infant social 
behaviors like breastfeeding and SSC activate maternal touch and 
smell somatosensory afferents that promote antistress effects 
that reduce blood pressure (Handlin et al., 2012)and cortisol 
(Handlin et al., 2009)and promote sedative effects that solicit 
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a calm mood and less anxiety (Nissen, Gustavsson, Widstrom, & 
Uvnas-Moberg, 1998; Uvnas-Moberg, 1998b). Physiologically, 
Uvnas-Moberg supports oxytocin’s antistress and sedative 
properties by emphasizing that the hormone is produced in the 
supraoptic (SON) and paraventricular (PVN) nuclei of the 
hypothalamus. When triggered, oxytocin is released into 
circulation from PVN neurons found in the pituitary. Beyond the 
HPA, PVN neurons extend to many other areas like the limbic 
system, vagal motor and sensory nuclei, spinal cord and 
preganglionic sympathetic neurons. Receptors that enable 
oxytocin to act have been found in the uterus with effects that 
activate the central nervous system (Uvnäs-Moberg, 1996). This 
allows oxytocin to have multiple functions beyond milk ejection, 
like stress modulation. 
As mentioned previously, antistress effects (Uvnas-Moberg, 
1998a)that result in positive mood and decreased anxiety have 
also been found among mothers with premature infants through 
tactile stimulation (Ahn, Lee, & Shin, 2010; Holditch-Davis et 
al., 2014). Additionally, reciprocal effects of maternal-infant 
behaviors like SSC positively influence human milk volume and 
lactation (Acuna-Muga et al., 2014; Chatterton et al., 2000; 
Heidarzadeh, Hosseini, Ershadmanesh, Gholamitabar Tabari, & 
Khazaee, 2013). To evaluate effects of SSC on human milk volume, 
Hurst et al. (1997) conducted a retrospective chart review 
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comparing 24 hour milk volumes of mothers of ventilated low 
birth weight infants compared to mothers without SSC 
intervention. Mean 24 hour milk volumes at 2, 3, and 4 weeks 
after delivery were compared with those of a retrospective 
control group from the 12 month period immediately preceding the 
introduction of SSC in the neonatal intensive care unit. Data 
analysis revealed a strong linear increase in milk volume in the 
SSC group compared to no change in milk volume in the control 
group.  
These findings speculate that skin to skin contact and 
oxytocin release are positively correlated. Similarly, oxytocin 
is thought to be positively correlated with human milk volume 
because it is essential for the expulsion of human milk from the 
mammary gland in lactating mothers. While it may be safe to 
assume that SSC positively correlates with human milk volume, 
dose responses of human milk volume relative to SSC frequency, 
duration and oxytocin release have yet to be determined.  
Restrictions for measuring plasma oxytocin levels require the 
use of multiple invasive blood draws or an indwelling line due 
to its pulsatile nature. To circumvent these constraints, the 
use of salivary oxytocin has recently gained popularity (Horvat-
Gordon, Granger, Schwartz, Nelson, & Kivlighan, 2005). Further 
exploration of basal salivary oxytocin will contribute to the 
reliability of salivary oxytocin in research and enhance the 
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knowledge of biobehavioral science associated with oxytocin 
secretion and SSC.   
 
Summary 
Mothers of premature infants experience immediate maternal-
infant separation, delayed onset of breastfeeding, poor suckling 
and biologic effects of maternal stress and anxiety. Compounding 
effects of these stressors inhibit the secretion of oxytocin and 
affect the ejection reflex. A poor ejection reflex perpetuates a 
cycle that negatively affects the amount of human milk expelled 
from the mammary glands. This in turn leads to altered human 
milk synthesis and insufficient human milk volume. 
Mediating interventions aimed to repair human milk 
synthesis and galactokinesis like skin to skin contact is 
suspected to ameliorate maternal psychological stress responses 
and improve the amount of oxytocin secreted yielding more milk 
ejected from the mammary gland. However, the true relationship 
between SSC and basal oxytocin levels have yet to be determined 
to fully understand the clinical significance of SSC on human 
milk volume. The proposed logic model (Figure 1) aims to fill 
this gap by determining how SSC frequency and duration influence 
basal oxytocin and other co-variants like human milk volume 
under similar conditions.  
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Table 1.Physiology of Lactogenesis and Galactokinesis 
  
Mechanism Process Trigger Physiology 
    
Lactogenesis 
 
Lactogenesis is a 
two stage process 
 
Stage I - The 
onset of human 
milk synthesis 
during the second 
trimester of 
pregnancy.  
 
Stage II - Within 
four days 
postpartum, 
increasing 
prolactin levels 
result in copious 
milk synthesis  
 
Infant 
Suckling  
After birth, the 
placenta is expelled and 
progesterone levels 
decline rapidly. This 
abrupt withdrawal of 
progesterone removes the 
inhibitory effect of 
progesterone and 
triggers lactogenesis in 
the presence of high 
plasma concentrations of 
prolactin secreted from 
the anterior pituitary 
Galactokinesis Galactokinesis is 
a process 
responsible for 
the ejection of 
human milk from 
the mammary gland  
 
Infant 
Suckling   
 
Conditioned 
Responses 
like infant 
crying prior 
breastfeeding 
 
Breast 
massage 
In response to infant 
suckling, impulses from 
sensory stimulation of 
nerve terminals in the 
areola travel to the 
central nervous system 
triggering a pulsatile 
release of oxytocin from 
the posterior pituitary  
 
Oxytocin is then carried 
through the blood stream 
to the mammary gland 
where it interacts with 
specific receptors on 
the epithelial cells.  
 
Oxytocin binds to 
receptors located on 
milk-secreting alveoli 
in the ducts, initiating 
contraction of the 
cells, which resulting 
in expulsion of milk 
from the gland  
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Table 2. Biobehavioral Factors that Influence Human Milk Volume 
 
 
Psychologic     Physiologic    Behavioral   Biologic Social 
Determinants  
     
Grief Mode of Delivery  Bond/Attachment Gestational 
Age 
Race 
Anxiety 
Fatigue 
Stress 
Delivery Trauma  
Comorbidities  
Endocrine 
Deficiency 
Nipple Stimulation 
Feeding Frequency 
Motivation 
Maternal Age 
Parity 
Body Mass 
Index 
Economic Status 
WIC* Participant 
Transportation 
Separation Medications Social Support Breast 
Anatomy 
Education Level 
Pain Hemodynamic 
Status 
Cardiac Disease 
Infant Temperament 
Formula 
Supplementation 
Pacifier Usage 
Suckle Reflex 
 
Marital Status 
     
 
*(WIC) Women Infant and Children Government Nutrition Program 
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Figure 1. Logic Model: Salivary Oxytocin and Skin to Skin  
Contact among Lactating Mothers of Premature Infants Model 
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CHAPTER THREE: 
METHODS  
 
Design 
This descriptive, repeated measures design explored the 
relationship between basal salivary oxytocin and SSC among 
lactating mothers with hospitalized premature infants.  
 
Setting 
BayCare Health System is a community based health care 
system made up of 14 hospitals that serve the Tampa Bay, Saint 
Petersburg and Clearwater areas. Morton Plant Mease (MPM) 
Hospital is a 687-bed facility with over 25 specialty services 
located in Clearwater, Florida. Of these specialty services, 
obstetric services account for over 3,000 deliveries per year 
with a 10 bed, semi-private room level II Neonatal Intensive 
Care Unit (NICU). St. Joseph’s Women’s Hospital (SJWH) is the 
largest birthing facility within the BayCare network. It is 
located in Tampa, Florida and accounts for over 6,000 births 
annually with 49 Level III private room infant beds and 15 Level 
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II private room infant beds. Both facilities are fully staffed 
with a neonatologist or nurse practitioners that tend to the 
NICU 24 hours a day. Mothers with infants admitted to the NICU 
at both facilities have high breastfeeding initiation rates 
close to 95%. Sufficient lactation support is available to NICU 
mothers at SJWH and MPM with daily lactation consultants, 
adequate hospital grade breast pumps and highly skilled nursing 
staff trained in lactation support. In addition to lactation 
support, SSC is routinely practiced within the guidelines 
outlined by the BayCare SSC evidence based clinical standards 
and protocols. In addition, MPM and SJWH utilize the BayCare 
network electronic medical record (EMR) that may be helpful for 
the research team to verify demographic and outcome measures. 
 
Participants  
Twenty lactating mothers and their premature infants born 
37 weeks and 0 days – 22 weeks and 0 days of gestational age 
were enrolled in the study.  
 
Inclusion Criteria  
Postpartum lactating females that: 1) are 0 - 7 days 
postpartum, 2)intend to breastfeed or breast pump, 3) initiate 
breastmilk expression within 12-24 hours after birth, and 4) 
have performed SSC with her neonate at least once since delivery 
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were included in the study. In addition to this inclusion 
criteria, participants were able to speak and read English or 
Spanish and have access to a telephone with mode of 
transportation to and from the hospital until infant discharge. 
Neonatal infants born 37 weeks and 0 days – 22 weeks and 0 days 
of gestational age admitted to the NICU were enrolled into the 
study after parental consent. 
 
Exclusion Criteria  
Mothers with maternal diagnoses or behaviors 
contraindicated in breastfeeding, polydrug use, human 
immunodeficiency virus (HIV), galactosemia, active tuberculosis 
(TB), radioactive isotopes, chemotherapy, or active herpes 
lesions on the breast(2012) or taking medications that may 
affect salivary oxytocin assay like antidepressants, 
psychotropic or dopamine agonist/antagonist medications  were 
excluded from the study. Premature infants unable to perform SSC 
(e.g. umbilical intravenous lines, terminal conditions, surgical 
emergencies and congenital anomalies) were also excluded from 
the study.  
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Measures  
Demographic Data and Medical History  
Standard socio-economic demographic and medical history 
data (Appendix A) were collected at baseline in English or 
Spanish by self-report and verified with the EMR for neonatal 
and maternal subject information. A chart audit was completed to 
update demographic or medical history information at all data 
collection time points (baseline, session 1, and session 2).  
 
Variables 
Independent Variable (Skin to Skin Contact)  
SSC frequency and duration was documented by each mother in 
a daily tracking log (Appendix B). Metrics were recorded in 
minutes per SSC session with start time, stop time, and daily 24 
hour total minutes. Additional co-variants, such as infant 
gestational age, weight, feeding method (bottle, tube feeding, 
breastfeeding), and nutrition source (breastmilk, formula, donor 
milk or mixed) and nipple stimulation (pumping or breastfeeding) 
were also documented in the tracking log by self-report.  
 
Dependent Variable Collection (Salivary Oxytocin) 
Salivary samples were collected at 4 time points per 
participant by the drool method (Appendix C) and handled with 
the specimen handling procedure in Appendix H. Sample collection 
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was timed for 5 minutes by participants at each time point and a 
protease inhibitor (aprotinin) was immediately added prior to 
centrifugation, aliquotted and frozen in a freezer located in 
the hospital at -60°C. Frozen samples were batched once a month 
and then transported to the College Of Nursing Biobehavioral 
laboratory in a cooler and stored at −80°C. After specimens were 
thawed and dried down, salivary samples were prepared for assay 
utilizing the enzyme-linked immunosorbent assay (ELISA) kit 
manufacture procedure (Enzo Life Sciences Product. Catalog 
Number ADI-900-153). Each dried sample was reconstituted in 
assay buffer to concentrate the sample and assayed in duplicate. 
The assay protocol utilizes a polyclonal antibody to 
competitively bind oxytocin prior to incubating specimens 
overnight at 4°C. After incubation, excess reagents were washed 
and the enzymatic reaction was stopped and read at 405nm 
immediately. Oxytocin concentration was calculated by 
immunoassay software utilizing a logistic curve fitting program.  
 
Procedures  
Approvals  
Institutional Review Board (IRB) approvals from University 
of South Florida and BayCare Health System at Morton Plan Mease-
Saint Anthony Hospital and St Joseph’s Women’s Hospital was 
obtained prior to enrolling participants.   
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Consent, Recruitment and Screening 
Twenty-five postpartum lactating mothers were screened for 
inclusion criteria (Appendix D) by collaborating co-
investigators (neonatologist and advanced practice nurses) within 
24-48 hours post-delivery and prior to maternal discharge from 
the hospital. Mothers that met inclusion criteria (N = 20) were 
approached by co-investigators to evaluate interest in 
enrollment. Mothers who expressed interested in enrolling in the 
study were referred to the Principal Investigator (PI) by co-
investigators or given a recruitment flyer (Appendix E) to 
contact the PI directly. The PI provided additional information 
at the patient bedside prior to obtaining informed consent. 
Mothers were oriented to the study protocols and consent 
document by the PI in a quiet and private area using clear and 
simple language. Adequate time to read the informed consent 
document was given to allow for all questions to be answered. 
Comprehension of the research protocol and consent was ensured 
by querying the individual in regards to salient talking points 
in the checklist provided in Appendix G. After consent, 
participants were supplied with data collection materials and 
assessed for demographic and medical history data. A $20 gift 
card and honorarium receipt (Appendix I) was offered for 
participation of the study upon completion to reduce attrition 
from the study. 
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Data Collection Procedure 
Data collection among participants included the following 
intervals: baseline, session 1 and session 2. Baseline data 
collection began on the day of consent where an overview of the 
benefits of SSC and hospital protocol was provided concurrent 
with critical study elements defined in the consent form. After 
obtaining consent, participants were supplied with data 
collection materials, maternal and infant demographic/medical 
history questionnaire, instructions on SSC, breastmilk 
expression and drool method procedures for salivary oxytocin 
during session 1 and session 2. At the end of session 2 the PI 
reconciled and compiled the participant’s tracking log data and 
updated maternal and infant medical history information verbally 
or via hospital EMR.  
 
Skin to Skin Contact  
Mothers were asked to self-report SSC data in their 
tracking log immediately after consent for up to 7 days 
depending upon neonatal discharge from the hospital. The PI 
screened for missing data by verifying entries of SSC 
frequency/duration and co-variant data after session 1 and 
session 2 with the mother. Missing data was corrected by the 
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mother or PI by the end of session 2. A summary of data 
collection procedures has been provided in Table 3. 
 
Salivary Oxytocin 
Samples were collected at 4 time points for all lactating 
mothers. Participants were asked to arrive at the NICU at 9:00 
am each morning of saliva sample collection. Mothers were 
instructed to eat breakfast from 7:00 – 8:30 am and not to eat, 
brush, floss or use mouthwash one hour prior to collection. 
Participants were also notified to avoid caffeine, alcohol, and 
nicotine smoke and to report any extreme tooth decay or 
gingivitis. Immediately prior to collecting salivary samples, 
participants were asked to rinse their mouth with water to 
remove any food particles. To avoid potential hormone variations 
relative to diurnal rhythm, samples were collected no earlier 
than 9:00 am. Salivary oxytocin has been found to be elevated 
within 30 minutes post breast pumping/breastfeeding or during 
pumping/breastfeeding (Rosemary et al., 2009). In keeping with 
these parameters, basal salivary samples were collected prior 
placing the neonate SSC at least 30 minutes post milk expression 
or breastfeeding to avoid suckle induced oxytocin release. 
Samples collected with any nipple stimulation or suckling during 
SSC was documented on the daily tracking log and considered for 
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recollection if feasible. Specimens collected under SSC 
intervention were collected within the last 5-10 minutes of SSC 
while the infant is still being held by the mother (i.e. 55-60 
minute time point of SSC) due to oxytocin’s pulsatile nature and 
short-half-life.  
 
Data Analysis  
Power analysis for this exploratory research was not 
feasible because statistical data on basal oxytocin in 
comparison to SSC has never been reported. MPM NICU census 
estimates 20 premature infants were admitted per month with 
approximately 50% eligible for SSC with a length of stay of 
seven to fourteen days. Feasibly, these admission rates indicate 
that 25 mother-infant dyads (5 per month) could be recruited 
over a six to eight month study period with the anticipation 
that a minimum of 20 ( 80 observations = 40 with no SSC and 40 
post SSC) would continue through the study for the 7 day time 
frame.  
 
Preliminary Analysis 
For testing Specific Aim 1: Explore the relationship 
between oxytocin and SSC among lactating mothers with 
hospitalized premature infants, the basal oxytocin measured by 
saliva sample with and without SSC on each day was computed to 
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form a new measure.  The two differences were used as the 
repeated measures of the true difference variable. A mixed 
effects model that fits the true difference variable in the 
previous step as the dependent variable with other controlled 
variables including frequency and duration of SSC as the 
independent variables was determined by the lowest Akaike 
information criteria (AIC).  
 
Additional Analysis  
Further analysis for Specific Aim 1 utilized paired sample 
t test to compare within-session and within-subject data to 
determine acute and sustained effects of SSC on basal oxytocin. 
Acute effects were assessed by determining within-session 
effects by analyzing the difference between the with and without 
oxytocin measures per session 1-2. Sustained effects were 
analyzed by the single measure within-subject data to determine 
the difference between two time point changes in salivary 
oxytocin (i.e. session 1 and session 2) over time per subject. 
 
Limitations  
Recruitment limitations secondary to the complexity of 
consenting premature mothers due to environmental and emotional 
stressors were avoided at time of consent with the inclusion of 
language and mode of transportation. Additionally, while most 
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mothers are discharged from the hospital within 2-3 days post-
delivery, many return to visit their infants daily to administer 
hands on care and promote bonding. Offering an honorarium to 
participants also minimized enrollment limitations by reducing 
attrition from the study.  
 
Protection of Human Subjects  
Human Subjects Involvement, Characteristics and Design  
Twenty-five lactating mothers and their premature infant 
were screened for eligibility for the study. Mothers and infants 
with maternal diagnoses/behaviors contraindicated in 
breastfeeding were excluded from the study as well as premature 
infants unable to perform SSC. Collaborating neonatologists and 
clinical nurses trained on the study protocol recruited 
participants prior to meeting the PI. The PI made weekly contact 
with mothers who consented to monitor compliance of SSC self-
report, assure accuracy of salivary sample collection and 
encouraged continued participation of the study. Confidentiality 
was maintained by removing identifying information, assigning 
study identification numbers to all data and securing the code 
in a locked cabinet. Sources of maternal demographic and medical 
history data were abstracted from the medical record and 
documented on case report forms (CRF). Saliva samples and CRFs 
were only labeled with the subject number and only the PI could 
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link the study subject with the sample. Data maintained 
electronically was password protected.  
 
Potential Risks  
The risks of performing SSC and collecting salivary samples 
were minimal. Before and after SSC, electrocardiogram and pulse 
oximeter devices monitored neonatal heart rate, respirations and 
oxygen saturation. On the occasion that the neonatal vital signs 
range outside of normal parameters, i.e. bradycardia or oxygen 
desaturation, will trigger alarms for the attending practitioner 
or bedside nurse to respond and assess the situation.  
 
Inclusion of Women and Minorities  
Women were included in the study. Twenty mothers and their 
premature infant born 37 weeks and 0 days – 22 weeks and 0 days 
of gestational age were enrolled. Presumably, infants enrolled 
in the study were of the same ethnicity as their mother. 
Targeted distribution of subjects included mothers of all 
ethnicities and infants of both gender types.  
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Table 3. Data Collection Procedure Summary 
 
 Baseline Session 1 Session2 
 
Time Frame 
 
0-7 days post 
delivery 
 
0-3 days post 
consent 
 
3 days post 
session 1 
Data Collection Informed 
consent 
Demographics 
Medical History 
Saliva Sample 
SSC tracking 
lod data 
verified and 
transcribed 
Medical Hx 
update 
Saliva Sample 
SSC tracking 
lod data 
verified and 
transcribed 
Medical Hx 
update 
# saliva samples 0 2 2 
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CHAPTER FOUR: 
RESULTS 
 
 
 
Restatement of the Problem and Study Aim 
 
In the United States, prematurity remains one of the top 
three leading causes of death annually. Exclusive human milk 
feedings have been known to reduce infant mortality. 
Unfortunately, mothers of premature infants are challenged with 
multiple stressors that affect their ability to provide 
exclusive human milk feedings to their infants. Compounding 
effects of these stressors inhibit the secretion of oxytocin 
hormone and affect the ejection reflex. A poor ejection reflex 
perpetuates a cycle that negatively affects the amount of human 
milk expelled from the mammary glands. This in turn leads to 
altered human milk synthesis and insufficient human milk volume. 
Mediating effects of skin to skin contact (SSC) between a mother 
and her neonate is suspected to repair altered lactogenesis and 
human milk volume but the true relationship between SSC and 
basal oxytocin levels have yet to be determined.  
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In this chapter results of the research design discussed in 
chapter 3 aims to better understand the true relationship 
between basal salivary oxytocin levels and SSC among lactating 
mothers with hospitalized premature infants by answering the 
following research questions:  
  
1a. Does maternal basal salivary oxytocin differ across 7 days     
in mothers before SSC?  
1b. Does SSC frequency affect basal salivary oxytocin levels?  
1c. Does SSC duration affect basal salivary oxytocin levels? 
   
 
Data Collection Methods 
 
Variables identified in the logic model (Figure1, Chapter 
2) were measured under similar conditions by limiting inclusion 
criteria to: 1) postpartum mothers of premature infants born 37 
weeks and 0 days – 22 weeks and 0 days of gestational age, 2) 
mothers that had given birth within 0 -7 days, 2) mothers that 
intended to breastfeed/pump, 3) mothers that initiated breast 
pumping within 12-24 hours after birth and 4) mothers that 
implemented SSC with her neonate at least once since giving 
birth. Those with maternal diagnoses or behaviors 
contraindicated in breastfeeding, polydrug use, HIV, 
galactosemia, active TB, radioactive isotopes, chemo therapy, 
active herpes lesions on the breast or taking medications that 
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may affect salivary oxytocin assay like antidepressants, 
psychotropic or dopamine agonist/antagonist medications were 
excluded from the study.  
 
Sample 
Early recruitment at Morton Plant Hospital initially met 
recruitment goals of 5 per month until mid-recruitment time due 
to a reduction in NICU census. To increase participant 
eligibility, recruitment was sought at St. Joseph’s Women’s 
Hospital after IRB approval. Ongoing recruitment continued for 
an additional two months at both facilities and ended after nine 
months of recruitment due to grant funding limitations. A total 
of twenty-five postpartum lactating mothers were screened by 
collaborating neonatologists and advanced practice nurses for 
inclusion criteria at participating neonatal intensive care 
units (NICU) within the BayCare Health System. Of the twenty-
five recruits, one declined to participate because she felt 
uncomfortable performing SSC with her neonate and four were 
excluded because of limited transportation, polydrug use or 
inability to meet inclusion criteria.  The remaining twenty that 
met full inclusion criteria were approached by the PI and 
consented to participate (N= 20 mother-infant dyads) in the 
study. Demographic and social determinant information were 
collected via self-report questionnaire at time of consent and 
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summarized in Table 4. Additional physiologic and co-variant 
characteristics discussed in the literature review and outlined 
in the study logic model are included in Table 5 and Table 6.  
 
Differences among Sample Characteristics  
Differences in social determinant and physiologic factors 
among sample participants were determined via one-way ANOVA 
using SPSS software. Since maternal age has been known to 
predict premature birth and early lactation failure (Avery, 
Duckett, Dodgson, Savik, & Henly, 1998; Beta, Akolekar, Ventura, 
Syngelaki, & Nicolaides, 2011; Furman, Minich, & Hack, 2002) the 
sample size was categorized into two groups based on maternal 
age. Group one (n=10) included post-partum mothers less than 31 
years of age and Group two (n=10) included post-partum mothers 
greater than 31 years of age. Social determinant factors were 
dichotomized for race (1=white,0=black), insurance (1=private, 
0=Medicaid), marital status (1=single,0 = married) and WIC 
eligibility (1= yes, 0=no). There were no outliers, as assessed 
by boxplot; data were normally distributed for each age group, 
as assessed by Shapiro-Wilk test (p > .05); and there was 
homogeneity of variances, as assessed by Levene's test of 
homogeneity of variances (p = .781 and p =.932). Differences 
between age group across marital status (F(1,18)= 0.184,p = 
0.673), race (F(1,18) = 0.275,p = 0.660), and insurance (F(1,18) 
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= 0.184, p = 0.673), were not significant. WIC eligibility was 
the same across both age groups (p = 1.000). 
Physiologic factor differences (Table 7) were also 
determined via one-way ANOVA per age group. Mode of delivery was 
dichotomized (1= vaginal delivery, 0 = cesarean delivery), 
comorbidities were categorized by three levels (0 = none, 1 = 
hypertension/preeclampsia, 2 = endocrine/thyroid disease), first 
pregnancy status, or primigravida, was dichotomized (1=yes and 0 
= no) and both gestational age (GA) and infant weight were 
continuous raw score variables. Data based on these parameters 
were normally distributed among both age groups for infant 
weight, comorbidities and primigravida by Shapiro-Wilk test (p > 
.05) with no outliers as assessed by boxplots. Mode of delivery 
did have two extreme outliers identified via box plots for age 
group one. Errors in data entry were assessed to determine 
probable cause for outliers with no need for correction. 
Homogeneity of variances for infant weight, comorbidities and 
primigravida were also determined by Levene's test of 
homogeneity of variances (p = 0.631, p =0.192, p = 0.865, and p 
=.065). Mode of delivery and GA did not have homogeneous 
variances (p =.001). Continued data analysis with ANOVA testing 
was not performed with variables that had outliers or non-
homogeneous variance (mode of delivery and GA) due to the 
violation of ANOVA assumptions. For the remaining variables that 
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met the assumptions of ANOVA, no significant differences were 
identified between age groups for comorbidities (F(2,17)=0.119,p 
= 0.888), primigravida (F(1,18)= 0.275,p = 0.660)and infant 
weight (F(1, 18)= 2.165, p = 0.158.  
 
Dependent Variable Data Collection and Measurement  
 
 Maternal saliva samples (n= 76) were collected at 4 time 
points during two 90-minute sessions at the bedside of the 
neonate in the NICU. Due to early neonatal discharge for 
participants 16 and 20 specimen sample sizes differ by two units 
per session. Salivary samples were collected over 5 minutes by 
the drool method (Appendix C) in the amount of 3-5 milliliters. 
To maintain the integrity of the samples repeat freeze and thaw 
times were avoided with careful specimen handling (Appendix I) 
as recommended by the Enzo Life Sciences Product enzyme-linked 
immunosorbent assay (ELISA) oxytocin kit manufacture procedure 
(Catalog Number ADI-900-153). Immediately after collection ten 
microliters of Aprotinin was added to each specimen, kept cold 
on ice and transported to the laboratory for centrifugation X 
1500 rpms for 10 minutes at 4 degrees centigrade. Specimens were 
then aliquoted in 1 ml tubes and promptly frozen at negative 60-
70 degrees within one hour of collection. Frozen samples were 
batched monthly and transported to the College Of Nursing 
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Biobehavioral laboratory in a cooler with dry ice to be stored 
at −80°C until ready for assay.  
When ready for assay specimens were prepared utilizing the 
manual’s 14 step ELISA procedure with the exclusion of 
extraction columns. In exchange for the use of extraction 
columns, the kit manufacturer advised to follow the methodology 
utilized by Feldman, Gordon, and Zagoory-Sharon (2010) where 
thawed specimens were dried down via lyophylizer overnight and 
reconstituted in enzyme immunoassay (EIA) buffer with a higher 
concentration. Once reconstituted, specimens were assayed in 
duplicate with paired standard samples and incubated overnight 
at 4°C. After incubation all the wells were washed, emptied and 
prepared for the second one hour incubation period after adding 
p-nitrophenyl phosphate (pNpp) substrate solution to each well. 
Post incubation the enzymatic reaction was stopped and the plate 
was read at 405nm immediately. Oxytocin concentration in 
picograms per milliliter (pg/ml) was calculated by the 
immunoassay PRISM software utilizing a 4 parameter logistic 
curve. Specimens with an intra-assay coefficient of variation 
(CV) greater than 15 (n=7) were repeated, excluding participant 
4 at time point 1 with a CV of 17 percent due to insufficient 
quantity of specimen available. 
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Dependent Variable Validity and Reliability 
 
The study’s protocol for specimen handling and ELISA was 
tested with two control samples within child-bearing age. 
Control one (C1) was a 24 year old lactating post-partum female 
and control two was a 36 year old non-lactating female. To 
account for circadian rhythm and variation associated with day 
and time both specimens were collected after 9am on the same 
date and time. Results of both control samples (Table 8) 
detected normal salivary OT concentration based on previous 
research and provided reassurance that the study protocol for 
handling and processing saliva specimens maintain the integrity 
of the sample. 
To determine if the OT ELISA kit was a good measure of OT, 
assay validity and reliability were tested by the manufacturer’s 
analysis of sensitivity, precision and cross reactivity. In the 
product manual the manufacturer references the use of the 
National Committee for Clinical Laboratory Standards evaluation 
protocols and guidelines to test for sensitivity by determining 
the average optical density bound for forty eight wells (M 0.67, 
SD 0.03) compared to the average optical density for forty-eight 
wells with standard number 7 (M .61, SD 0.02) with a detection 
limit determined at 2 SD from the zero along the standard curve 
that resulted in 15.0 pg/ml (ie.- standard 7 OT concentration).   
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The manufacturer describes testing for intra-assay 
precision with 20 replicates of three controls containing OT in 
a single assay and inter-assay as using controls of varying OT 
concentrations in 17 assays over several days. Results of the 
intra-assay test detected OT concentration that ranged 39.9 -
363.7 pg/ml with a CV range of 10-13 percent and the inter-assay 
tests resulted in OT concentrations that ranged 47-398 pg/ml 
with a CV range of 11-21 percent.  
Cross reactivity test results among 13 related compounds 
were also included in the kit manual to be sure similar 
molecular structures like OT did not interfere with accuracy of 
OT measurement. For this test, the manual describes dissolving 
each compound in assay buffer first and then serially diluting 
each compound to concentrations of 10,000 pg/ml to 0.6 pg/ml 
prior to being measured in the OT assay. Percent cross 
reactivity for 11 compounds reached less than 0.02% with 2 
compounds measuring close to 7%.  
 
Preliminary and Exploratory Data Analysis   
Dependent Variable  
Maternal OT salivary samples (n= 76) were collected during 
two sessions for a total of 4 time points over a 7 day time 
frame. During session one (n = 20), time point one of salivary 
OT was collected under basal conditions with no SSC and time 
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point two under SSC intervention with a mean of 50 minutes of 
SSC duration (SD 15.80 minutes). During session two (n=18), time 
point 3 of salivary OT was again taken under basal conditions 
with a mean interval of 3 days (SD 1.20) between sessions. The 
final repeated measure at time point 4 of salivary OT was 
collected under SSC intervention with a mean of 54.70 minutes of 
SSC duration (SD 13.20 minutes). Descriptive data analysis 
performed via SPSS in Table 9 document the differences between 
OT specimen sample size and OT concentration per time point with 
further descriptive data for CV and time of collection in Table 
10 for the entire sample (n=76).  
Other differences among OT concentrations (Table 9) based 
on conditions at time of collection (neonatal day of life (DOL), 
time, and interval) are presented in Table 11 and 12. Figures 2 
and 3 provide a preview of the relationship OT concentrations 
(n=76) per time of day with higher values in the afternoon near 
1400 military time and a continuous increase in value over time 
per DOL. To determine the significance of these conditions at 
time of collection on OT concentration a one-way ANOVA was 
performed to compare time of collection (1 = AM, 2 = PM), 
interval between repeated measure category (1 = < 3 days, 2 = 3 
days, 3 = > 3 days) and day of life (DOL) at 3 levels (1 = < 5 
days, 2 = 5-7 days, 3 = > 7 days). Through boxplots, no 
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extraneous outliers were detected more than 2 box-lengths from 
the edge of the box. Homogeneity of variance was satisfied with 
Levene’s test (p = > .05) for all variables. The differences 
between OT and DOL (F(2, 73) = 0.3.420,p =0.038) was significant 
whereas time of collection(F(1,74) = 2.907,p = 0.092) and 
interval between sessions were not. Follow up data analysis via 
Post HOC Tukey test among the DOL > 7 days group (M = 310 pg/ml, 
SD = 160 pg/ml) compared to the DOL < 5 days group (M = 219 
pg/ml, SD = 105 pg/ml), was statistically significant (p = .040) 
with a mean increase of 92 pg/ml, 95% CI [-10.2, 162]. 
 To remove pooled sample bias for time and DOL among samples 
collected under basal conditions (n=36), the sum of saliva 
specimens collected with no SSC (time point 1 and time point 3) 
were combined to signify basal OT (M 250 pg/ml, SD 148 pg/ml). 
Results of the scatter plots (Figures 4 and 5) replicate peak 
concentrations of basal OT near 1400 military time and support 
an increase in value of OT over time per DOL. Despite these 
results, the difference between basal OT and DOL are not 
significant (F(2, 36) = 1.860, p = 0.171). 
 
Independent Variable  
 
 Daily SSC was collected via self-report diary data over a 7 
day time frame. Metrics were recorded in minutes per SSC session 
with start time, stop time, and daily 24 hour total minutes. 
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Missing data was corrected by the mother or verified by 
electronic medical records by the end of the 7th day study 
period. Descriptive statistics via SPSS (Table 13) separates SSC 
frequency by number of SSC sessions (M = 4 sessions, SD = 1 
session) measured over the participant’s enrollment period and 
the average amount of SSC measured in minutes per day (M 68 
minutes per day, SD 27 minutes per day); whereas SSC duration (M 
291 minutes, SD 165 minutes) accounts for the total amount of 
SSC measured in minutes over the participant’s enrollment 
period. 
While the study enrollment period was targeted for 7 days, 
the number of days of diary data reported by participants ranged 
from 2-6 days and is the reason for inflated SD measurements. To 
account for this variability, Table 14 shows the adjusted SSC 
frequency (M 4 sessions, SD 0.1 sessions; M 68 minutes per day, 
SD 6 minutes per day) and duration (M 291 total minutes, SD 6 
total minutes) variables clustered within the number of days of 
diary data category (1 = less than 5 days, 2 = 5 days and 3 = 
more than 5 days).  
 
Exposure of the Independent Variable on the Dependent Variable 
 At time of consent, SSC exposure was controlled by 
requiring implementation of SSC at least once prior to study 
enrollment. Post consent, SSC diary data suggest a gradual 
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increase in SSC exposure over time and time point (Figure 6 and 
7). Descriptive statistics in Table 15 display differences among 
the sample and mean SSC exposure prior to each OT time point 
collection (M = 141 minutes, SD 81; M 133 minutes, SD 96; M 235, 
SD 140; M 300, SD 149). Table 16 includes descriptive statistics 
that compare differences among SSC exposure and OT 
concentrations per time point. Preliminary data analyses predict 
how the dependent variable and independent variable are 
associated via line of fit scatter plot projections in Figures 
8-12.  
 
Acute Effects of the Independent Variable  
Oxytocin pre and post scores for session 1 (time point 1 
vs. time point 2) and session 2 (time point 3 vs. time point 4) 
were measured per interval of repeated measures via paired t-
test to determine acute effects of SSC on OT. Concentrations for 
both sessions were normally distributed with no outliers. Pre 
and post paired t test of OT at Session 1 were not significant 
(Table 17). However, pre and post paired t- test scores for 
session 2 (n = 10) were significant with a moderate effect size 
(t(9) = -71.30, p = 0.047, d = 0.7). Session 2 paired means were 
also correlated with r = 0.935 and p = <0.001 (Table 17 and 18). 
 
 
64 
 
 
Sustained Effects of the Independent Variable  
Mean scores for time point 1 (n=20) and time point 4 (n=18) 
were measured to determine if OT had sustained effects of SSC 
over time. No outliers in the data set were identified as 
assessed by inspection of a boxplot for values greater than 1.5 
box-lengths from the edge of the box per time point. Mean scores 
for time point 1 (M 236 pg/ml, SD 105 pg/ml) and time point 4 (M 
269 pg/ml, SD 170 pg/ml) were correlated (r= 0.483, p = .042) 
but paired t-test was non-significant (t(17) = -1.708, p = 
0.106). Analysis per interval data counter these findings and 
indicate that paired t-test results for sustained effect time 
points collected with a 3 day interval are significant with a 
small effect size (t(9) = 2.425, p = 0.038, d =.15). 
 
 
Statistical Analysis for Specific Aim 1 
 
Question 1 
    To answer question 1 of the specific aim: “Does maternal 
basal salivary oxytocin differ across 7 days in mothers before 
SSC?” differences between basal OT concentrations were 
determined via scatter plots, Pearson correlations and paired-
samples t-test to compare the mean difference between paired 
observations of basal OT at time point 1 and time point 3. 
Paired OT samples with a CV < 15 were included for analysis 
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(n=17 pairs). Figure 13 scatter plot suggests that OT 
concentrations collected under basal conditions are positively 
associated indicating an increase in means of basal OT from 234 
pg/ml (SD 107 pg/ml) at time point 1 to 257 pg/ml (SD 125 pg/ml) 
at time point 3. Pearson correlations (n=17) confirm that the 
relationship between both time points are positively associated, 
but the measures are not correlated (r=.449, p = .071). Paired-
samples t-test for basal OT at time point 1 and time point 3 are 
also non-significant (t(16) = .756, p = .461). 
 
Question 2 
 
To answer question 2 of the specific aim: “Does SSC 
frequency affect basal salivary oxytocin levels?” Initial data 
analysis procedures discussed in the original proposal proposed 
the use of a difference variable (i.e. – OT timepoint1-OT 
timepoint2) as the dependent variable in a mixed multilevel 
model analysis, however the use of the difference variable would 
be an inappropriate measure of SSC frequency or duration on OT 
because it focuses on the acute affect OT rather than the 
variance explained of the dependent variable under basal 
conditions.  To remove this bias from the entire OT sample 
(n=76), the dependent variable was redefined as the group mean 
of OT at time point 1 and time point 3 (basal OT) to only 
include OT levels corresponding with no SSC intervention (n=20).  
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Plot diagrams (Figure 14) describing basal oxytocin and SSC 
frequency measured in mean minutes per day where categorized as 
low = < 50 minutes of SSC per day, medium = 50-75 minutes, 
moderate = 75-85 minutes and high = > 85 minutes of SSC per day.  
Preliminary analyses with scatter plot interpolation identify 
peak basal oxytocin under moderate SSC exposure. Elevated mean 
concentrations of basal OT (Table 18) for moderate measures of 
SSC frequency per day (M 572.92 pg/ml, SD 451 pg/ml) support 
this prediction. To determine if these measures of SSC frequency 
significantly affect basal OT concentrations, a 1 level fixed 
effect and 4 level random effects multilevel model analysis was 
structured with an AIC of 226.85. The omnibus test for the model 
was significant (F(1, 16) = 101, p = <0.001) indicating that 
average basal OT concentrations of the sample population differ. 
Fixed effects from the intercept was also significant t(16) = 
6.389, p = < 0.001) indicating that the average basal OT 
concentration was 480 pg/ml with a standard error of 75 pg/ml. 
While coefficient estimates per each SSC frequency parameter 
were not significant (p = .814, p = .867, p = .589) coefficient 
estimates for moderate SSC exposure (92.66 pg/ml, standard error 
167 pg/ml) indicate that basal OT concentrations exposed to 75-
85 minutes of SSC per day are 92 pg/ml higher than the group 
mean (480 pg/ml).  The variance component explained by the model 
at level 1 representing SSC frequency within-groups was 
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significant (p = < 0.005). An interclass correlation (ICC) among 
SSC frequency groups was not calculated because the variance 
estimate was zero. 
 To determine if a different measure of SSC frequency better 
fit the data, SSC frequency per mean number of sessions (Table 
14) compared to basal OT concentrations was analyzed in a 1 
level fixed effect and 3 level random effects multilevel model 
analysis with an AIC of 238.45. The omnibus test for the model 
was significant (F(1, 17) = 110.99, p = <0.001) indicating that 
average basal OT concentrations of the sample population differ. 
Fixed effects from the intercept was also significant t(17) = 
5.955, p = < 0.001) indicating that the average basal OT 
concentration was 539 pg/ml with a standard error of 90 pg/ml. 
Coefficient estimates per each SSC frequency parameter were not 
significant (p = .313, p = .685). The variance component 
explained by the model at level 1 representing SSC frequency per 
number of sessions within-groups was significant (p = < 0.004). 
An interclass correlation (ICC) among SSC frequency groups was 
not calculated because the variance estimate was zero. 
 While both models resulted in a significant omnibus test 
indicating mean basal OT differ across all SSC frequency groups, 
model 1 was the best fitting model that explained the effects 
and variance within and between SSC frequency groups because it 
had the lower AIC (Table 20). 
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Question 3 
 
To answer question 1b of the specific aim: “Does SSC 
duration affect basal salivary oxytocin levels?”, sustained 
effects of SSC duration in minutes per enrollment period on OT 
collected under basal conditions were determined via scatter 
plots, descriptive data and a mixed effects multilevel model 
analysis. Preliminary data analysis via scattered plots in 
Figure 15 and 16 and Table 21 suggest that basal OT levels 
increase as SSC duration increases over time.    
To determine if sustained effects of SSC duration affect 
basal OT, SSC total duration in minutes clustered within number 
of days of diary data discussed in Table 14 were structured 
within a 1 level fixed effect and a 3 level random effects 
model. The omnibus test for the model was significant (f(1, 17) 
= 109.11, p = < 0.001) indicating that the average basal OT 
among the sample population differed. Fixed effects from the 
intercept was also significant (t(17) = 6.867, p = < 0.001) 
indicating that the average basal OT was 491.70 pg/ml with a 
standard error of 71.60 pg/ml. Coefficients of SSC group 1 (M 
281 total minutes, SD 80 total minutes) indicate that basal OT 
concentrations are 48 mg/ml higher than average mean basal OT 
(491 pg/ml). The variance component at level 1 representing SSC 
duration between and within-groups was significant (p = 0.004). 
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An interclass correlation (ICC) among SSC frequency groups was 
not calculated because the variance estimate was zero. 
 
Additional Data Analysis 
Relationship between OT and Covariants  
Preliminary analyses of co-variants were determined via 
descriptive statistics, scatter plots and Pearson correlations 
in Tables 22 and 23 and Figures 17, 18 and 19. Results show that 
basal OT correlates with OT collected under SSC intervention (r 
= .575, p =.008) indicating that as basal OT increases OT 
concentrations under SSC intervention continue to increase as 
well. Similarly, HM volume correlates with SSC frequency and 
duration (r = .750, p = < .001; r = .585, p = .007), indicating 
that as SSC increases HM volume continues to increase over time. 
Beyond this relationship, HM volume does not directly predict or 
significantly affect OT collected with or without SSC. 
 
Predictors of Salivary OT under SSC Intervention  
Since inclusion criteria required the implementation of SSC 
prior OT collection, all basal OT measures were influenced by 
sustained effects of SSC. The use of regression analysis 
determined how much variation of OT with SSC intervention can be 
explained by covariant independent variables in the logic model. 
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In the first regression analysis, the proportion of variance 
explained by SSC frequency and duration variables (SSC number of 
episode per day, SSC mean minutes per day and SSC total duration 
in minutes) on OT with SSC (time point 2 and time point 4) was 
45% with a moderate to large effect size (adjusted R
2
 = .53).The 
assumptions of linearity, independence of errors, 
homoscedasticity, unusual points and normality of residuals were 
all met. SSC frequency and duration variables were not 
significant predictors of OT with SSC (F(1, 3) = 1.353, p 
=.293). However, Pearson correlations indicate that OT with SSC 
and SSC duration have a significant positive correlation 
(r=.041, p = < .05). Unstandardized coefficients indicate that 
for every 1 unit SSC total minutes increases when all other 
independent variables are held constant, OT with SSC increases 
1.225 units.  Unstandardized coefficients are in Table 23. 
   To determine if the influence of OT with SSC would be 
affected by other covariates identified in the logic model of 
the study design, a second regression analysis was performed 
with the inclusion of the following co-variants clustered by 
number of days of diary data: 1) total human milk volume per 
milliliters (HM total), 2) nipple stimulation at time of 
collection, and 3) feeding method (where 1= nasogastric tube, 2 
= oral feeding, 3 = breastfeeding with nasogastric tube, 4 = 
exclusive breastfeeding), birth weight and gestational age.  
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Proportion of variance explained by all five variables was 68% 
with a low effect size (adjusted R
2
 = .271). The assumptions of 
linearity, independence of errors, homoscedasticity, unusual 
points and normality of residuals were met via scattered plots, 
casewise P-P plot, review of all standardized residual cases 
less than ±3 SD for outliers and Durbin-Watson statistic of 
1.555. Human milk volume, nipple stimulation, method of feeding, 
birth weight and gestational age were not significant predictors 
of OT with SSC (F(1, 5) = 2.409, p =.089). Pearson correlations 
indicate that OT with SSC, birth weight, and gestational age 
have a significant positive correlation (r =.005, r = .021). 
Unstandardized coefficients are in Table 24. 
 
Summary and Conclusion 
Results of this research were conducted on a homogenous 
sample with no significant deviations among demographic and 
biologic factors (race, age, insurance, marital status infant 
weight, comorbidities and gravidity). Similarly, salivary OT was 
well controlled for variability associated with time and 
interval collected with a non-significant F test.  
Over time OT was found to increase per day of life (F(2, 
73) = 0.420, p = 0.038) with a mean increase of 92 pg/ml for the 
entire sample (n=76). Via scatter plots mean basal OT also 
increased per DOL and time point (M 234 pg/ml, SD 26 pg/ml time 
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point 1; M 257 pg/ml, SD 30 pg/ml time point 3) but the 
relationship between basal OT, DOL and time point was not 
significant (F(2, 36) = 1.860, p = 0.171; t(16) = .756, p = 
.461). In comparison to SSC exposure, basal OT was found to have 
a meaningful amount of dependence on SSC frequency (t(16) = 
6.389, p = < 0.001) and SSC duration (t(17) = 6.867, p = < 
0.001) with a high level of variance explained by within groups 
(p = .005, p = .004). Coefficient estimates for moderate SSC 
frequency exposure indicate that basal OT concentrations exposed 
to 75-85 minutes of SSC per day are 92 pg/ml higher than the 
group mean of 480 pg/ml.  Through regression analysis OT 
measured with SSC also correlated with SSC duration (r=.041, p = 
< .05). Unstandardized coefficients indicate that for every 1 
unit SSC total minutes increases when all other independent 
variables are held constant, OT with SSC increases 1.225 units. 
HM volume correlates with SSC frequency and duration (r = .750, 
p = < .001; r = .585, p = .007), indicating that as SSC 
increases; HM volume continues to increase over time. Beyond 
this relationship, HM volume does not directly predict or 
significantly affect OT collected with or without SSC.  
Implications of these findings on the true relationship 
between basal salivary oxytocin levels and SSC among lactating 
mothers with hospitalized premature infants will be presented in 
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Chapter 5 including clinical significance and recommendations 
for further course of study.  
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Table 4. Sample Demographic and Social Determinant Factors 
  
ID AGE RACE Ethnicity Insurance Marital 
Status 
WIC 
Eligible 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
 
19 
31 
23 
19 
27 
30 
31 
35 
28 
19 
35 
30 
33 
30 
38 
34 
31 
33 
27 
40 
 
Black 
White 
Black 
White 
White 
White 
White 
White 
White 
Black 
White 
White 
White 
White 
White 
White 
White 
Black 
White 
Black 
 
Non-Hispanic 
Non-Hispanic 
Non-Hispanic 
Hispanic 
Non-Hispanic 
Non-Hispanic 
Non-Hispanic 
Non-Hispanic 
Non-Hispanic 
Hispanic 
Hispanic 
Hispanic 
Non-Hispanic 
Non-Hispanic 
Non-Hispanic 
Non-Hispanic 
Non-Hispanic 
Non-Hispanic 
Hispanic 
Non-Hispanic 
 
Medicaid 
Medicaid 
Medicaid 
Self-pay 
Medicaid 
Private 
Private 
Private 
Private 
Medicaid 
Self-pay 
Medicaid 
Private 
Private 
Private 
Medicaid 
Private 
Private 
Private 
Medicaid 
 
 
Single 
Single 
Single 
Single 
Married 
Married 
Married 
Married 
Married 
Single 
Single 
Single 
Married 
Married 
Married 
Single 
Married 
Single 
Single 
Single 
 
 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
Yes 
Yes 
Yes 
No 
No 
No 
Yes 
No 
Yes 
Yes 
Yes 
 
 
Note. Social economic status classified via insurance. WIC = Women Infant and Children 
Government Nutrition Program 
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Table 5. Sample Physiologic Factors 
  
ID Age 
Gestational 
Age 
Gravida Para 
Mode of 
Delivery 
Comorbidities Medications 
1 19 29 2 2 Vaginal - - 
2 31 34 2 1 Vaginal Hypertension PNV 
3 23 34 1 1 Vaginal Thyroid disease - 
4 19 34 2 2 Vaginal - - 
5 27 34 6 5 Vaginal - - 
6 30 32 1 2 Vaginal Hypertension PNV 
7 31 33 1 1 Vaginal - - 
8 35 33 2 2 Vaginal - PNV 
9 28 33 1 1 Vaginal - Analgesic 
10 19 34 1 2 Cesarean - Iron supplement 
11 35 32 1 4 Cesarean - Analgesic 
12 30 34 2 1 Cesarean - Analgesic 
13 33 34 2 2 Vaginal - - 
14 30 34 2 2 Vaginal - PNV 
15 38 35 1 4 Cesarean Thyroid disease - 
16 34 36 3 2 Cesarean - PNV 
17 31 34 2 2 Vaginal - - 
18 33 35 4 1 Cesarean Hypertension PNV 
19 27 31 2 1 Cesarean Hypertension PNV 
20 40 37 2 2 Cesarean - Iron supplement 
& Analgesic 
 
Note. Gravida = number of pregnancias, Para= number of living children, PNV = prenatal 
vitamin 
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Table 6. Sample Co-Variant Factors 
  
ID GA 
Infant  
Weight 
Infant 
weight in 
grams 
Feeding 
Method 
Nutrition Source 
Nipple 
Stimulation 
via 
breastfeeding 
1 29 3lbs 1oz 1389 NG MBM No 
2 34 4lbs 0oz 
1814 NG 
Mixed No 
3 34 3lbs 14oz 
1758 NG 
Mixed No 
4 34 3lbs12oz 
1701 Mixed 
Mixed Yes 
5 34 4lbs 15 
2239 NG 
DM/MBM Yes 
6 32 4lbs 12oz 
2155 Sham 
MBM Yes 
7 33 3lbs 2oz 
1417 NG 
MBM No 
8 33 4lbs 0oz 
1814 Mixed 
Mixed Yes 
9 33 3lbs 14oz 
1758 Mixed 
Mixed Yes 
10 34 3lbs 6oz 
1503 Mixed 
Mixed No 
11 32 5lbs 0oz 
2268 Mixed 
MBM No 
12 34 5lbs 7oz 
2466 NG 
Mixed No 
13 34 6lbs 7oz 
2920 BF 
Mixed Yes 
14 34 4lbs 9oz 
2070 Mixed 
Mixed Yes 
15 35 6lbs 3oz 
2807 Mixed 
MBM Yes 
16 36 6lbs 10oz 
3005 Mixed 
Mixed Yes 
17 34 5lbs 12oz 
2608 Mixed 
Mixed Yes 
18 35 4lbs 4oz 
1928 Mixed 
Mixed No 
19 31 2lbs 10oz 
1190 NG 
Mixed No 
20 37 5lbs 11oz 
2580 PO 
Mixed No 
 
Note. GA= Gestational age. Feeding method categories (NG) Nasogastric tube (PO),= Oral 
or Per os, Sham (breastfeeding and NG),(BF) = Exclusive breastfeeding, (NG/PO/BF)= 
Mixed. Nutrition source categories MBM = maternal breastmilk, DM = donor milk, mixed = 
formula with MBM or DM  
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Table 7. Descriptive Statistics for Normally Distributed 
Physiologic Factors by Age Group 
 
Variable Clustered by 
Age group 
N Minimum Maximum Mean SD 
Age group > 31 years      
GA (weeks) 10 32 37 34.40 1.430 
Weight (grams)  10 1417 3005 2239 532.64 
Primigravida  10     
Comorbidities 10     
Age group < 31 years      
GA (weeks) 10 29 34 32.80 1.69 
Weight (grams) 10 1190.00 2807.00 1899.40 500.82 
Primigravida  10     
Comorbidities 10     
 
Note. GA = gestational age in weeks, Primagravida= 1 = yes, 0 = no, weight = infant 
birth weight in grams, comorbidities = 0 = none, 1 = hypertension/preeclampsia, 2 = 
endocrine/thyroid disease 
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Table 8. Salivary Oxytocin Controls for Handling and ELISA 
Procedure 
 
ID 
Days Post 
Delivery 
Condition OT (pg/ml) CV  
C1 7 Lactating 63.39 
 
 3% 
 
C2 N/A Non-lactating 
 
168.15 
 
    2% 
  
Note. C1 = control one, C2 = control 2 
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Table 9.Salivary Oxytocin Descriptive Statistics per Time Point 
 
Time point N 
 
Minimum 
 
Maximum 
 
Mean 
(pg/ml) 
SD 
(pg/ml) 
OT1 20 113.44 441.77 240.67 96.03 
OT2 20 63.66 471.79 203.70 108.12 
OT3 18 36.03 524.64 262.56 124.21 
OT4 18 65.03 704.02 296.77 170.32 
 
Note. OT1= basal OT at time point 1 with no SSC , OT2= OT at time point 2 with SCC, 
OT3 = basal OT at time point 3 with no SSC, OT4 = OT at time point 4 with SSC 
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Table 10. Salivary Oxytocin Descriptive Statistics for 
Coefficient of Variation and Time Collected  
 
Variable N 
 
Minimum 
 
Maximum 
 
Mean 
 
SD 
 
CV 76 0% 17% 5% 4% 
Time 76 910.00 1830.00 1213.61 228 minutes 
  
  Note. CV = inter-assay coefficient of variation, Time = military time 
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Table 11. Salivary Oxytocin Concentration per Interval between 
Repeated Measures at Time of Collection 
 
Interval   Time Point N Minimum Maximum Mean 
(pg/ml) 
SD 
(pg/ml) 
< 3days OT1 5 184.00 429.00 259.40 98.43 
OT2 5 93.00 342.00 173.40 105.79 
OT3 3 207.00 524.00 350.00 160.75 
OT4 3 125.00 380.00 279.66 135.90 
3 days OT1 10 119.00 441.00 243.10 104.77 
OT2 10 79.00 471.00 226.80 119.73 
OT3 10 130.00 450.00 267.60 110.10 
OT4 10 74.00 704.00 338.90 192.51 
> 3 days OT1 5 113.00 343.00 200.00 100.14 
OT2 4 64.00 335.00 192.75 110.90 
OT3 4 36.00 239.00 159.75 87.14 
OT4 5 65.00 409.00 222.20 138.40 
 
Note. OT1= basal OT at time point 1 with no SSC , OT2= OT at time point 2 with SCC, 
OT3 = basal OT at time point 3 with no SSC, OT4 = OT at time point 4 with SSC. 
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Table 12. Salivary Oxytocin Concentration and Time of Collection 
Variables per Time Point 
 
Time Point  Variable N Minimum Maximum Mean SD 
 
OT1 OT pg/ml 20 113.44 441.77 240.69 96.04 
Time  20 915.00 1800.00 1212.0 237.73 
DOL days 20 2.00 8.00 4.4500 1.57 
OT2 OT pg/ml 20 63.66 471.79 203.76 108.09 
Time 20 1025.00 1830.00 1307.2 223.92 
DOL days 20 2.00 8.00 4.4500 1.57 
OT3 OT pg/ml 18 36.03 524.64 262.68 124.13 
Time 18 910.00 1725.00 1111.6 211.69 
DOL days 18 5.00 11.00 7.4444 1.78 
OT4 OT pg/ml 18 65.03 704.02 296.86 170.28 
Time 18 1010.00 1827.00 1213.2 211.19 
DOL days 18 5.00 11.00 7.4444 1.78 
 
Note. OT1= basal OT at time point 1 with no SSC , OT2= OT at time point 2 with SCC, 
OT3 = basal OT at time point 3 with no SSC, OT4 = OT at time point 4 with SSC, OT = 
oxytocin, Time = military time, DOL = days of life. 
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Time of Collection in Military Time  
 
 
Figure 2. Trend of Oxytocin Concentration per Time of Day 
(N=76) 
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Figure 3. Trend of Oxytocin Concentration per Neonatal Day of 
Life (N=76) 
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Figure 4. Trend of Basal Oxytocin Concentration per Time of 
Day (n=37) 
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Figure 5. Trend of Basal Oxytocin Concentration per Neonatal Day 
of Life (n=37) 
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Table 13. Skin to Skin Frequency and Duration Descriptive 
Statistics 
  
Variable N Minimum Maximum Mean SD 
SSCTmin 20 30.00 630.00 291.20 163.54 
SSCF 20 1.00 7.00 4.25 1.77 
SSCfmeanperday 20 17.00 117.00 67.90 26.85 
Note. SSCTmin = total amount of SSC measured in minutes over the participant’s 
enrollment period. SSCF= number of SSC sessions measured over the participant’s 
enrollment period SSCfmeanperday = average amount of SSC measured in minutes per day. 
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Table 14. Skin to Skin Contact Frequency and Duration 
Descriptive Statistics Clustered within Number of Days of Diary 
Data  
 
Variable N Minimum Maximum Mean SD 
SSCTmin 20 281.80 294.50 291.20 5.57 
SSCF 20 4.14 4.40 4.25 .10 
SSCfmeanperday 20 63.75 78.80 67.90 6.48 
 
Note. SSCTmin = total amount of SSC measured in minutes over the participant’s 
enrollment period. SSCF= number of SSC sessions measured over the participant’s 
enrollment period SSCfmeanperday = average amount of SSC measured in minutes per day. 
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Neonatal Day of Life (DOL) at Time of Maternal 
Saliva Collection 
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Figure 6. Skin to Skin Exposure by Neonatal Day of Life  
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Time Point of Oxytocin Collection 
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Figure 7. Scatter Plot of Skin to Skin Exposure per Time 
Point 
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Table 15. Descriptive Statistics for Skin to Skin Exposure prior 
Oxytocin Time Point Collection  
 
 
 
Time point 
N Minimum Maximum Mean 
(minutes) 
SD 
(minutes) 
OT1 11 33.00 300.00 141.27 81.23 
OT2 20 30.00 390.00 133.05 95.67 
OT3 18 50.00 510.00 235.11 139.77 
OT4 18 105.00 570.00 300.78 149.23 
 
Note. OT1= basal OT at time point 1 with no SSC , OT2= OT at time point 2 with SCC, 
OT3 = basal OT at time point 3 with no SSC, OT4 = OT at time point 4 with SSC.  
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Table 16. Descriptive Statistics for Skin to Skin Exposure and 
Oxytocin Concentration per Time Point Collection  
 
Time Point   Variable N Minimum Maximum Mean SD 
 
OT1 SSC minutes 11 33.00 300.00 141.27 81.22 
OT pg/ml 20 113.44 441.77 240.69 96.04 
OT2 SSC minutes 20 30.00 390.00 133.05 95.66 
OT pg/ml 20 63.66 471.79 203.76 108.09 
OT3 SSC minutes 18 50.00 510.00 235.11 139.77 
OT pg/ml 18 36.03 524.64 262.68 124.13 
OT4 SSC minutes 18 60.00 570.00 286.61 159.54 
OT pg/ml 18 65.03 704.02 296.86 170.28 
 
Note. OT1= basal OT at time point 1 with no SSC , OT2= OT at time point 2 with SCC, 
OT3 = basal OT at time point 3 with no SSC, OT4 = OT at time point 4 with SSC.  
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Oxytocin pg/ml  
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Figure 8. Relationship between Skin to Skin Exposure and 
Oxytocin Concentration (n=76) 
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Basal Oxytocin pg/ml at Time Point 1 
Figure 9. Basal Oxytocin Concentration and Skin to Skin 
Exposure at Time Point 1 (n=11) 
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Oxytocin pg/ml at Time Point 2 
Figure 10. Skin to Skin Exposure and Oxytocin Concentration 
at Time Point 2 (n=20)  
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Basal Oxytocin pg/ml at Time Point 3 
Figure 11. Basal Oxytocin Concentration and Skin to Skin 
Exposure at Time Point 3 (n=18)  
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Oxytocin pg/ml at Time Point 4 
Figure 12. Skin to Skin Exposure and Oxytocin Concentration 
at Time Point 4 (n=18)  
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Figure 13. Relationship between Basal Oxytocin Repeated Measures 
(n=20) 
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Table 17. Acute Effects of Skin to Skin on Oxytocin by Interval  
 
 
Interval                       Session  N Correlation        
 
Days between 
sessions 
 
    
3days  Session 1 10 .463  .178 
 Session 2 10 .935  .00* 
4days  Session 1 4 -.639  .361 
 Session 2 4 -.528  .472 
 
 
 
 
Note.* p <.05, session 1= oxytocin collected at time point 1 vs time point 2, session 
2= oxytocin collected at time point 3 vs time point 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sig 
100 
 
 
Note.* p <.05, session 1= oxytocin collected at time point 1 vs time point 2, session 
2= oxytocin collected at time point 3 vs time point 4 
 
 
 
 
 
 
 
 
  
Table 18. Acute Effects of Skin to Skin on Oxytocin Paired T-
Test 
 
 Interval                        Session  
Mean 
(pg/ml) 
SD 
(pg/ml) 
T test 
(+/-) 
df Sig 
1day  Session 1 88.000 103.23 1.205 1 .441 
2days  Session 1 206.00 172.53 1.659 1 .340 
 Session 2 10.500 101.12 .147 1 .907 
3days  Session 1 16.300 117.06 .440 9 .670 
 Session 2 -71.300 97.75 2.307 9 .047* 
4days  Session 1 -8.7500 198.20 .088 3 .935 
 Session 2 -75.000 215.58 .696 3 .537 
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Figure 14. Plots Describing Basal Oxytocin and Skin to Skin 
Contact Frequency  
 
Skin to Skin Frequency by Category  
Skin to Skin Frequency by Category  
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Table 19. Descriptive Statistics for Basal Oxytocin per Skin to 
Skin Frequency  
 
 
SSC Frequency 
Category 
N Mean 
(pg/ml) 
SD 
(pg/ml) 
Coefficient 
of Variation 
low 5 451.26 198.64 44.0% 
medium 5 459.59 209.56 45.6% 
moderate 2 572.92 451.15 78.7% 
high 8 480.26 162.20 33.8% 
Total 20 477.11 197.95 41.5% 
 
Note. low = < 50 minutes of SSC per day, medium = 50-75 minutes, moderate = 75-85 minutes and 
high = > 85 minutes of SSC per day  
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Table 20. Basal Oxytocin and Skin to Skin Contact Frequency 
Fixed effects 
 
 
 
 
 
Note.* p <.05, low = < 50 minutes of SSC per day, medium = 50-75 minutes, moderate 
= 75-85 minutes and high = > 85 minutes of SSC per day 
 
 
  
SSC 
Frequency 
Parameter 
Coefficient 
(pg/ml) 
Std. 
Error 
(pg/ml) 
  df t Sig. 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Intercept 480.26 75.06 16 6.398 .000* 321.14 639.39 
low -28.10 121.03 16 -.240 .814 -285.58 227.58 
medium -20.67 121.03 16 -.171 .867 -277.25 235.91 
moderate 92.66 167.84 16 .552 .589 -263.15 448.48 
high - - . . . . . 
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Table 21. Basal Oxytocin and Skin to Skin Contact Duration 
Descriptive Statistics 
 
 
   
Variable N Minimum Maximum Mean 
 
SD 
Basal OT(pg/ml) 20 195.57 891.93 477.11 197.95 
SSC Total 
Duration in 
minutes  
20 30.00 630.00 291.20 163.53 
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Figure 15. Skin to Skin Duration per Participant 
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Figure 16. Relationship between Skin to Skin Duration and Basal 
Oxytocin 
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Skin to Skin Duration in Minutes 
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Table 22. Covariant Data Descriptive Statistics 
 
 
 N Minimum Maximum Mean SD 
OT with SSC (pg/ml) 20 92.54 1001.10 473.166 261.44 
HM total in ml 20 101.00 5978.00 1440.75 1517.93 
Nipple 
stimulation 
20 0 1 0 0 
Feeding method 20 1 5 3 1.90 
Note. OT with SSC = salivary oxytocin collected at time point 2 and 4) HM total = total human 
milk volume per milliliters (ml), nipple stimulation (1= yes, 0= no at time of collection), 
feeding method (1= nasogastric tube, 2= oral feeding, 3= breastfeeding with nasogastric tube, 4 = 
exclusive breastfeeding) 
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Figure 17. Scatter Plot of Basal OT and Human Milk Volume 
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Total Human Milk Volume in 
Milliliters 
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Figure 18. Scatter Plot of OT with SSC and Human Milk Volume 
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Figure 19. Scatter Plot of Basal OT and OT with SSC  
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Table 23. Covariant Data Correlations 
 
 
 
OTnoSSC OTwithSSC SSCTmin SSCF HMtotal 
OTnoSSC Pearson 
Correlation 
1 .575
**
 .091 -.026 -.223 
Sig. (2-tailed) 
 
.008 .702 .913 .344 
N 20 20 20 20 20 
OTwithSSC Pearson 
Correlation 
.575
**
 1 .399 .228 .141 
Sig. (2-tailed) .008 
 
.081 .335 .554 
N 20 20 20 20 20 
SSCTmin Pearson 
Correlation 
.091 .399 1 .842
**
 .585
**
 
Sig. (2-tailed) .702 .081 
 
.000 .007 
N 20 20 20 20 20 
SSCF Pearson 
Correlation 
-.026 .228 .842
**
 1 .750
**
 
Sig. (2-tailed) .913 .335 .000 
 
.000 
N 20 20 20 20 20 
HM total Pearson 
Correlation 
-.223 .141 .585
**
 .750
**
 1 
Sig. (2-tailed) .344 .554 .007 .000 
 
  
N 20 20 20 20 20   
 
Note.* p <.05. OTnoSSC = salivary oxytocin at time point 1 and 3; OTwithSSC = salivary 
oxytocin collected at time point 2 and 4; SSCTmin = total amount of SSC measured in 
minutes over the participant’s enrollment period. SSCF= number of SSC sessions 
measured over the participant’s enrollment period. HM total = total human milk volume 
per milliliters (ml), nipple stimulation (1= yes, 0= no at time of collection), 
feeding method (1= nasogastric tube, 2= oral feeding, 3= breastfeeding with 
nasogastric tube, 4 = exclusive breastfeeding) 
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Table 24. Unstandardized Coefficients for Skin to Skin Frequency 
and Duration 
 
                  Variable Unstandardized Coefficients t Sig. Partial 
Correlation 
 Std. Error 
 
 (Constant) 398.298 180.465 2.207 .042  
SSCTmin 1.225 .750 1.633 .122 .378 
SSCF -52.980 61.307 -.864 .400 -1.93 
SSCfmeanperday -.835 3.349 -.249 .806 .422 
 
Note. SSCTmin = total amount of SSC measured in minutes over the participant’s 
enrollment period. SSCF= number of SSC sessions measured over the participant’s 
enrollment period 
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Table 25. Covariant Unstandardized Coefficients on OT with SSC  
Note.* p <.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Varaibles Clustered by 
diarydatagroups 
Unstandardized 
Coefficients 
t Sig. Partial 
Correlations 
B Std. Error   
 (Constant) -106.19 220.92 -.481 .638   
HM total -.02 .04 -.600 .558 -.16  
Nipple 
stimulation 
69.79 153.04 .456 .655 
.12  
Feeding method 35.64 30.95 1.151 .269 .29  
Weight group 325.13 144.97 2.243 .042* .51  
GA group 121.03 85.05 1.423 .177 .36  
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CHAPTER 5: 
 
CONCLUSIONS 
 
 
Methods and Procedures  
This one-group, repeated measures design involved daily SSC 
via self-report diary data and maternal salivary OT with and 
without SSC at 4 time points over a 7 day time frame. 
Major Findings 
Mean levels of OT under basal conditions increased over 
time with a mean concentration of 234 pg/ml (SD 108 pg/ml) at 
time point 1 and mean concentration of  257 pg/ml (SD 125 pg/ml) 
at time point 3. Pearson correlations confirmed that the 
relationship between basal OT time points were positively 
associated, but the two were not significantly correlated 
(r=.449, p = .071) and were also non-significant via paired sample 
t-test (t (16) = .756, p= .461. Through mixed effects multilevel 
model data analysis, basal OT levels were found to have a 
meaningful amount of dependence on SSC frequency (t(16) = 6.389, 
p = < 0.001) and SSC duration (t(17) = 6.867, p = < 0.001) with 
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coefficient estimates that indicate that basal OT concentrations 
in women exposed to moderate levels of SSC (75-85 minutes of SSC 
per day) were 92 pg/ml higher than the group mean of 480 pg/ml. 
In addition, basal levels of OT were found to correlate with OT 
collected under SSC intervention (r= .575, p =.008) indicating 
that as basal OT increases OT under SSC intervention continues 
to increase as well. Similarly, HM volume correlated with SSC 
frequency and duration (r = .750, p = < .001; r = .585, p = 
.007), indicating that as SSC increases HM volume continues to 
increase over time. Beyond this relationship HM volume did not 
directly predict or significantly affect OT collected with or 
without SSC.  
Discussion 
Results of this research suggest that lactating mothers 
with premature infants sustain positive effects of SSC that 
increase basal OT secretion over time. Prior to this research 
salivary OT had never been measured during SSC in order to 
explore the relationship between basal OT and SSC among 
lactating mothers with hospitalized premature infants. These 
findings are unique and narrow the gap in the literature by 
adding a better understanding of the physiology of 
galactokinesis by satisfying three research questions. In 
relation to question 1a, maternal basal salivary oxytocin did 
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differ across 7 days in mothers before SSC but the relationship 
was non-significant. For questions 1b and 1c, SSC frequency and 
duration did positively affected basal salivary oxytocin levels 
over the enrollment period.  
Exposure of term infants to SSC intervention for 25 to 120 
minutes after birth, with or without early suckling, positively 
influences mother-infant interaction at 1 year of age compared 
to standard care that separates mother and infant at birth 
(Bystrova et al., 2009). For premature mother-infant dyads, 
separation at birth is common and often triggers episodes of 
maternal sadness, depression and anxiety (Carvalho, Martinez, & 
Linhares, 2008). Positive effects of OT secretion elicit 
maternal “feel good” responses that improve mood, reduce 
symptoms of stress, depression and anxiety while promoting 
social attachment (Pratt et al., 2015; Samuel et al., 2015; Tops 
et al., 2013; Uvnas-Moberg, 1996; Weisman, Zagoory-Sharon, & 
Feldman, 2013). SSC has also been known to reduce maternal 
stress and depression in NICU environments (Flacking, Thomson, 
Ekenberg, Lowegren, & Wallin, 2013; Holditch-Davis et al., 
2014). In this research, maternal benefits of OT secretion and 
SSC intervention are likely to manifest with routine SSC 
exposure (75-85 minutes per day) when OT levels are markedly 
higher and encouraged continuously (24 hours/7 days a week) in 
high tech neonatal environments(Nyqvist et al., 2010). 
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Findings of this dissertation research also provide new 
insight on the relationship of SSC on oxytocin and human milk 
volume. Due to lack of lactogenic hormone measurement in 
previous research (Hill et al., 1999; Hurst, 1997), gaps in the 
literature presumed that SSC yielded more HM volume because SSC 
increased oxytocin secretion thus allowing the expulsion of HM 
from the mammary gland. However, evidence from this research 
showed that OT did not correlate with HM volume and suggests 
that SSC serves as a mediator for HM volume in response to an 
increase in OT secretion. Recent findings by Acuna-Muga et al. 
(2014) published that mean human milk volumes were significantly 
higher during (107.7 mL) and after SSC (117.7 mL) compared to 
milk volumes obtained at the beside of the incubator (96.9 mL). 
Ongoing research aims to determine if milk expression conducted 
in proximity to the infant, particularly prior and during SSC is 
associated with higher milk volume via secondary data analysis. 
Limitations 
Measurement Error 
Large standard deviations among mean OT concentrations 
raise areas of concern regarding the accuracy, reliability and 
stability of OT measurement. McCullough, Churchland, and Mendez 
(2013) agreed that plasma OT measurement lacked reliability 
depending upon methodology and technique and suggested that an 
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accurate, specific, and readily available method for measuring 
OT be standardized in the field.  Likewise, Horvat-Gordon, 
Granger, Schwartz, Nelson, and Kivlighan (2005) reported that 
meaningful oxytocin levels may not be detected in saliva assay. 
However, more recent studies have successfully measured salivary 
oxytocin with a modified concentration or extraction procedure 
technique mentioned (Carter et al., 2007; Feldman, Gordon, & 
Zagoory-Sharon, 2011; Grewen, Davenport, & Light, 2010; White-
Traut et al., 2009). Results of this research contribute to 
salivary OT technique recommended by the manufacturer. While 
noticeable discrepancies were noted per basal OT time point with 
a standard deviation of 26 for time point 1 and standard 
deviation of 30 for time point 3, assay wells that measured 
standard controls of OT were within normal limits for each EIA 
kit assayed. Since OT is labile and pulsatile in nature (Ueda, 
Yokoyama, Irahara, & Aono, 1994) with a 5 minute half-life, such 
factors may contribute to discrepancies noticed among OT 
salivary concentration. Although important, these factors are 
difficult to control and require more rigorous research beyond 
the scope of this study.  
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Sample Size 
 Power analysis to determine sample size was not attainable 
because statistical data (ie. - sample means, alpha and effect 
size) on basal oxytocin in comparison to SSC had never been 
published. Feasible sample size was determined by NICU census 
data and budget restraints for a total of twenty participants 
yielding a sum of 76 observations. However, depending upon the 
test performed for data analysis, smaller sample sizes were 
required to answer each research question.  
For this research data analysis for a sample size of 17, 
paired sample t-test resulted in a non-significant t test. In 
hypothesis testing, a non-significant t test would indicate 
rejecting the null hypothesis where basal OT at time point 1 is 
not equal to basal OT at time point 3. Rejecting the null would 
then indicate that the alternative hypothesis would be true 
indicating that basal OT at time point 1 and time point 3 are 
the same. To determine the probability of rejecting the null 
hypothesis in error, both the effect size and power are 
considered given a certain sample size. Via G*Power 3.1.9.2 
(Faul, Erdfelder, Lang, & Buchner, 2007) the paired samples t 
test where OT at time point 1 mean was 234 pg/ml (SD 108 pg/ml) 
and OT at time point 3 was 257 pg/ml (SD 125 pg/ml) calculated 
an effect size of d=0.2 with a power level of 20%. Implications 
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of a small effect size and low power level suggest that results 
of the study were under powered for determining differences in 
basal OT over time and increases the probability of committing a 
type II (false-negative) error. To reduce the likelihood of type 
II error, findings of this research should be replicated in 
future studies with a larger sample size. An increase in sample 
size reduces the likelihood of results differing from the 
population, resulting in a significant t-test indicating that 
basal OT significantly differs over time (Banerjee, Chitnis, 
Jadhav, Bhawalkar, & Chaudhury, 2009).  
 
Design  
 Inclusion of a comparison or control group was also not 
feasible due to budget limitations of this research. Future 
studies comparing basal OT concentrations among mother-infant 
dyads that do not perform SSC would offer an unbiased estimate 
of basal OT concentrations over time. These findings would 
better explain trends of OT during the day, over time and by 
neonatal day of life. In addition, the exclusion of maternal 
stress also limits clear interpretations of SSC on OT and human 
milk volume. Psychological and physiological measures of stress 
are expected to decrease over time at 2, 4, and 6 weeks 
postpartum with no significant differences in cortisol and 
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oxytocin among mothers with non-nursing infants less than 1500 
grams (Chatterton et al., 2000). Measuring acute and sustained 
stress responses in the NICU will validate the use of SSC as a 
means to deregulated maternal stress responses to increase OT 
and possibly HM volume. 
Conclusions 
Preliminary findings of this study have a high level of 
significance for nursing science because it provides insight on 
the relationship between SSC and oxytocin hormone. This new 
understanding adds to the importance of continued SSC 
intervention to promote sustained effects of SSC on the 
physiology of galactokinesis and maternal mental health that 
improve mood and attachment behaviors. Preliminary data analyses 
also suggest that SSC mediates human milk volume in response to 
an increase in OT over time. Immunologic benefits of breast 
milk, consumed by the premature infant via exclusive human milk 
feedings, offers a significant contribution to neonatal health 
care outcomes by reducing the incidences of neonatal 
complications associated with premature delivery, such as 
sepsis, NEC, and death.  
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Recommendations 
Continued research comparing maternal salivary cortisol and 
OT with and without SSC will determine if SSC physiologically 
deregulates maternal stressors that influence OT secretion and 
HM volume. Presumably, OT increases under moderate levels of SSC 
exposure and SSC exposure positively correlates with human milk 
volume. Dose responses of SSC frequency, duration relative to 
human milk volume and oxytocin release are pending on-going data 
analysis.  
 
Funding for this research was provided by the Southern Nurse’s 
Research Society Dissertation Grant Award. 
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Appendix A: Demographics and Medical Information Questionnaire 
 
 
Participant ID: ____________   Date of Birth: ___/____/_____   Age ____  
 
Ethnicity 
Hispanic or Latino  Not Hispanic or Latino  
 
Race:  
 White  Black /African American  American Indian/Alaska Native  
 Asian  Pacific Islander  Other__________________________ 
 
Marital Status: Single  Married  Divorced  Widowed 
 
Insurance: Private  Medicaid  Self Pay 
 
 
Pregnancy and Birth Information: 
 
Date of Delivery: ___/____/_____   Time of Birth: _______  
 
Type of delivery:  Vaginal  Cesarean  
 
Gestational age at delivery: ______ weeks 
 
How many pregnancies have you had? ____ How many living children? ___ 
 
Did you take any medications during your pregnancy? Yes  No   
If yes please name the medications _______________________________ 
____________________________________________________________ 
 
Are you still taking these medications? Yes  No   
If yes please name which medications_______________________________ 
____________________________________________________________ 
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Did you experience any prenatal or delivery complications (for example - high 
blood pressure, preterm labor, severe illness, etc)? Yes  No   
If yes please explain ___________________________________________ 
____________________________________________________________ 
 
Do you have any extreme tooth decay or gingivitis? Yes  No  
 
Infant Information: 
 
Sex of baby  Male  Female 
 
Baby’s Birth Weight ________ lbs _______ oz (or) _________ gms   
 
Why is your baby receiving care in the NICU? 
___________________________________________________________ 
____________________________________________________________ 
____________________________________________________________ 
____________________________________________________________ 
 
Will your baby be receiving benefits form WIC?  Yes  No  
 
Have you breastfed your baby or pumped your milk since giving birth to your 
baby? Yes  No  
If yes what date & time? Date:  ___/____/_____    Time: ____:_____ am/pm 
 
Have you initiated skin-to-skin contact or kangaroo care since giving birth to your 
baby?  Yes    No  
If yes when? Date:  ___/____/_____     Time: ____:_____ am/pm 
 
Did you feel comfortable holding your baby skin-to-skin? Yes    No  
If no, please explain____________________________________________ 
 
Please provide any further information you would like to share about your 
experience. 
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
______________________________________________ 
 
Thank you for your time in completing this questionnaire. 
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Appendix B: Tracking Log Instructions 
 
After enrollment into the study please begin to track activities you perform related 
to skin-to-skin, saliva collection and infant feedings. Below is an example to 
follow: 
   
Tracking Log Day 1: 2 / 12 / 14 
     
Activity Start Time End Time Feeding Type Amount 
(ml/min) 
Minutes of SSC 
BP 6:00 am 6:20 am PM 10 ml - 
SSC 8:00 am 9:35 am - - 95 minutes 
BF 10:00 am 10:15am BF 15 minutes - 
B 10:30 am 10:45 am DM 30 ml - 
S 9:00 am 9:05 am - - 0 
      
      
      
      
      
      
      
Totals: 95 minutes 
 
Activity Legend: 
 
SSC – Skin-to-Skin Contact 
BF – Breastfeed 
BP – Breast pump  
S – Saliva Collection  
B – Bottle Feeding 
* - nipple stimulation during SSC 
 
Feeding Legend: 
 
BF - Breastfed 
PM – Pumped milk 
DM – Donor milk 
F – Formula 
TB – Tube feeding 
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Appendix C: Instructions for Drool Method Saliva Collection 
 
 
Supplies to be given the day of collection: 
 
2 Collection tubes (2ml Cryovials) 
Cup of ice 
 
 
Collection instructions: 
 
1. On the day of saliva collection arrive at the NICU at 9am. 
2. If upon arrival your baby is hungry and needs to breastfeed, nurse your baby 
or pump. Wait 30 minutes after the feeding prior to saliva collection.  
3. When ready for saliva collection, place both cryo vials in a cup of ice..  
4. Next, rinse your mouth with water and spit it out in a sink or cup for 
disposal. Mark the time of disposal in your tracking log. 
5. Over the next 5 minutes spit out all of the saliva that collects in your mouth 
into the collection tube without coughing or clearing your throat.  Mark the 
time you finish on your tracking log. 
6. Place the cap on the collection tube and place it back in the cup of ice. 
7. The PI will immediately label the tube with the collection date and time.and 
transport the specimen to the laboratory for processing. 
8. Place your baby skin-to-skin (try to avoid any nipple stimulation, 
breastfeeding or pumping during skin-to-skin). If nipple stimulation does 
occur during sample collections merely indicate it on your tracking form 
with a star. These samples may need to be recollected. 
9.  Right before removing your baby in skin-to-skin contact (at 55 or 60 
minutes of SSC) repeat steps 3-8 for the second saliva sample 
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Appendix D: Recruitment Screening  
Inclusion Criteria Screening: (no to any will be excluded) 
 
1. Mother is 0-7 days Postpartum  Yes  No 
2. Intends to breastfeed or breast pump  Yes  No  
3. Initiated breastmilk expression within 12-24  hours after birth  Yes  No  
4. Performed SSC with her neonate once since delivery  Yes  No  
5. Speaks and reads English or Spanish  Yes  No  
6. Access to a telephone  Yes  No  
7. Has a mode of transportation to and from the hospital  Yes  No 
8. Neonate born 37 – 22 weeks gestation & admitted to NICU  Yes  No 
 
Exclusion Criteria Screening: (yes to any will be excluded) 
  
1. Mother with maternal diagnoses/behaviors contraindicated in breastfeeding 
(polydrug use, HIV, galactosemia, active TB, radioactive isotopes, chemo therapy, active 
herpes lesions on the breast)  Yes  No 
2. Taking medications contraindicated in salivary oxytocin assay (antipsychotic 
medications)  Yes  No 
3. Premature infants unable to perform SSC (umbilical lines, terminal conditions, 
surgical emergencies, congenital anomalies)  Yes  No 
 
Eligible for study  Yes  No – place in PI box and text 813-469-3129 
 
Consented to participate?   Yes  No  
Date: ___/____/_____ 
 
Participant ID: ________ 
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Appendix E: Recruitment Flyer 
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Appendix G: Check List and Participant Instructions 
 
Meet with the Principal Investigator _____/______/_____ 
 
Complete Consent Form _____/______/_____ 
 
Complete Demographic Questionnaire_____/______/_____ 
 
Receive Participant Instructions & Supplies _____/______/_____ 
 
Collect and Store Saliva Samples (within 0-7 days after delivery and 3 days later) 
 
Day 1_____/______/_____  before SSC   after SSC  
 
Day 2_____/______/_____  before SSC    after SSC  
 
Complete Daily Tracking Log  
 
Day 1   Day 2    Day 3    Day 4    Day 5    Day 6    Day 7 
 
Submit Tracking Log, Forms and Samples to  
Principal Investigator by:                                   _____/______/_____ 
 
Receive your $20.00 Gift Card to Baby’s R Us_____/______/_____ 
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Instructions for Mothers Performing Skin-to-Skin Care 
 
 
Skin-to-skin contact is a safe practice that involves placing your naked baby on 
your bare chest. Premature babies benefit from skin-to-skin care because it 
increases their oxygen saturation, calms the baby, and regulates their heart rate, 
breathing and temperature. The hospital supports skin-to-skin care and routinely 
promotes when performed within their hospital guidelines.  
 
 
To perform skin-to-skin: 
 
1. First consult your baby’s nurse to see if it is safe to position your baby skin-
to-skin. 
2. When safe, prepare for skin-to-skin position by find a chair or recliner with 
pillows and footstool if available. 
3. Wear an open-front shirt or gown to allow direct skin-to-skin contact. 
4. Dress your newborn in only a diaper (a hat may be worn as well). 
5. Allow the nurse to switch the incubator temperature control from servo-
control to air temperature to prevent incubator cooling while newborn is 
being held. 
6. Remove your baby from the crib or isolate and place your baby chest to 
chest on your bare skin with your baby’s head in chin-tilt position. 
7. Hold your baby securely as you recline into a 45 degree angle.  
8. Wrap your gown or garment around the newborn and place a cover or 
blanket over your chest and the newborn. 
9. After five minutes if newborn’s feels too warm or temperature is greater than 
99.0 degrees F remove the cover blanket. 
10. Hold your newborn as long as desired (preferably a minimum of 1 hour) if 
newborn remains stable. 
11. Attempt to perform routine skin-to-skin contact when able.  
12. Record each time you perform skin-to-skin with your baby in your tracking 
log. 
13. After skin-to-skin, dress your baby and place them back in his/her crib or 
isolate 
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Instructions for Mothers Pumping in the NICU 
 
A hospital grade breast pump is preferred to help you build a good milk supply for 
your baby. Single and double pump setups are available. Double-pump setups will 
allow you to pump both breasts at the same time, but are not required.  
 
After you deliver ask a nurse to provide you with a hospital grade breast pump for 
your use during your hospital stay if you do not already have one. You should also 
ask for plastic storage bottles and lids to collect your milk in at each pump session. 
These storage bottles are for single use only and easily attach to the hospital pumps 
for your convenience.  
 
Each time you pump keep a daily record of the following information: 
 the date of each session, 
 start and end time of each pumping session,  
 amount of milk pumped each session, preferably in millimeters (ml) 
 daily 24 hour total of the amount of milk expressed. 
 
This will help you be more certain that you are producing an adequate milk supply 
for your baby. 
 
When to pump 
 
It is important for you to begin to pump your breast within four to six hours after 
delivery, or as soon as you are physically able, especially if you are unable to 
breastfeed your baby right away. This, along with continued frequent pumping, 
will help stimulate your breast to produce milk and encourage adequate milk 
production. The best time to pump is the same time you expect to feed your baby, 
at least every 2-3 hours. This usually averages out to be 8-10 times a day.  
 
 
Pumping Instructions 
 
1. Wipe down the pump and wash your hands prior each pumping session. 
2. Attach a clean setup with storage bottles to the pump (each bottle should only 
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collect expressed milk from one single pumping session.) 
3. Place yourself in a comfortable position 
4. Set the pump on minimum pumping force to begin, adjusting strength as 
needed.  
5. Pump breast for approximately 10-15 minutes. Remember this is just a rule of 
thumb. Mothers should concentrate more on their own milk flow and are 
encourage to pump at least two minutes after your milk flow stops to 
completely empty the breast. 
6. When finished pumping, take the breast pump setup apart and wash all parts in 
luke- warm soapy water, rinse, air dry and store until next use.  
7. Sterilize the pump accessories, excluding the tubing, by boiling them for 15 
minutes or putting them through the dishwasher once a day. Microwaveable 
sterilization bags may also be used as well. 
 
Labeling Your Milk 
 
Use a waterproof pen to label each bottle with your baby’s name and the date & 
time of collection. If the hospital provides preprinted labels please use them but be 
sure to verify that the name on the label is your baby’s each time you place a label 
on a bottle you just expressed.   
 
Storing Your Milk   
 
Unless there is a medical reason, you can save your breast milk to be used to feed 
your baby until he/she is ready to eat. During your hospital stay, properly label the 
provided storage bottles and deliver the breast milk to the NICU immediately after 
pumping to be placed in the refrigerator or freezer. Hospital freezer-storage 
containers for long term use are usually available, but may be limited to one 
container per baby. Any additional milk unable to be stored in the freezer container 
should be stored at home.  
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Appendix H: Salivary Oxytocin Assay Specimen Handling Procedure 
1. Wear gloves and prepare supplies for collection. 
2. Assist patient collect 3 -5 ml of saliva via drool method for 5 minutes.  
3. Immediately place saliva sample in a cup of ice and add 10 microliters (UL) of Aprotinin 
(PI) to 3 - 5 ml of saliva and transport on ice to the laboratory. 
4.      Spin saliva samples in centrifuge at 4 x 1000 rpms for 10 minutes at 4 degrees C. 
5.      Label 3  1.5 cryovials (clean tube) according to the labeling guidelines below with 
permanent marker and fill each vial with 1ml of supernatant.  
6.      Freeze immediately at -70 degrees C and store in freezer box located in the      
Microbiology Section of the laboratory within 30-60 minutes of collection. 
7.      Bach samples once per month and transport to the CON laboratory via dry ice. 
8.      Store samples in CON freezer at -80 degrees C until ready for Assay. 
 
Specimen labeling guidelines: 
001 – Participant ID 
XX/XX – Date 
0900 – time in military time 
#1-4 – time point of collection 
 Session 1 
#1 No SSC 
 #2 With SSC 
 Session 2 
 #3 No SSC 
 #4 With SSC  
 
 
 
 
 
139 
 
Appendix I: Honorarium Receipt 
Study: Skin to Skin Contact and Basal Salivary Oxytocin among    
Lactating Mothers of Premature Infants 
 
PI: Jessica M Gordon, MS, ARNP, CPNP-PC, CLC 
 
Funded By: Southern Nurses’ Research Society Dissertation Award 
 
BayCareIRB # - 2014.001 
USF IRB # - 00017904 
 
 
Participant reimbursement for time:     
You will be reimbursed for the time you are providing in order 
to complete your participation. A one-time receipt of a $20 gift 
card will be provided. 
 
 
I, ________________________________________,(print name) 
agree to this reimbursement for participation.  
 
I confirm that I have completed my participation in the study 
and a $20 gift card payment has been provided to me as 
reimbursement for my time.  I understand that payment will only 
be received one-time and the amount received will be equal to 
the amount outlined on this form.             
 
        
____________________________________                 ___________________________ 
                                 (print name)                                                                                                        (date of birth) 
 
____________________________________                 ___________________________ 
                                  (signature)                                                                                                                 (date) 
 
_______________________________________________________________________ 
                                                                                           (street address) 
_______________________________________________________________________ 
                 (city)                                  (state)                     (zip code) 
 
___________________________________                 ___________________________ 
                           (witness signature)                                                                                                           (date) 
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Appendix J: Institutional Review Board Letters 
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